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Summary 
 
 Mycobacteria, like other prokaryotic species, are able to accumulate large 
amounts of neutral lipids such as triacylglycerol (TAG) containing structures called 
lipid droplets (LDs). A growing body of evidence indicates the importance of the roles 
played by LDs in the pathogenesis of mycobacterial diseases. In particular, recent 
reports have shown that tubercular bacilli in lung granulomas are enriched in LDs. 
These TAG deposits are consumed when dormant bacilli are reactivated, suggesting 
that lipid storage probably contributes to mycobacterial survival during the latent 
and/or reactivation phase. The TAG degradation process catalyzed by lipolytic 
enzymes may release free fatty acids, which can be utilized as a carbon source during 
growth and infection processes. Several studies have explored the possibility of 
utilizing inhibitors to target these lipid-catabolizing enzymes for the treatment of latent 
tuberculosis. In addition to the lipolytic enzymes, there is also an interest in studying 
the non-lipolytic esterases, which aid mycobacterial survival under stress conditions 
by detoxifying toxic metabolites and drugs. Members of this family of enzymes are 
also considered to be opportunistic enzymes that generate energy from soluble TAGs 
and free-esters. 
 Our group has previously demonstrated that tetrahydrolipstatin (THL), an 
irreversible inhibitor of serine esterases, attenuates regrowth of dormant mycobacteria 
by preventing TAG breakdown. To better understand THL activity and its 
pharmacological implications in vivo, we used a novel chemical proteomic strategy to 
identify specific mycobacterial targets and to validate some of their biological 
Madhu Sudhan Ravindran 12 
activities. We report that THL targets the α/β-hydrolase family proteins, including the 
‘Lip family’ of enzymes and identified BCG2241c, lipD, lipM, lipN, Ag85c, lipI, 
lipH, lipW, BCG3408, BCG1252 and tesA as high confidence THL targets.  
 THL is a lipase inhibitor and lipases are hypothesized to be up-regulated 
during mycobacteria regrowth from non-replicating persistent (NRP) bacilli. 
Therefore, to obtain a functional insight into mycobacterial esterases and/or lipases in 
mycobacterial NRP, we extended our chemical-proteomic strategy to other disease-
relevant mycobacterial metabolic states, specifically NRP and regrowth from NRP. 
Interestingly, we observed that down-regulation of certain THL targets in the NRP 
phase, and the expression pattern was reversed during the subsequent regrowth. We 
further show that regulation of these genes occur at the proteomic level, maybe by 
post-translational modification mediated translocation, degradation or inactivation. 
Finally, among the high confidence THL targets, we selectively characterized lipH, a 
protein whose function was previously poorly defined, as an esterase with a preference 
towards short-chain free esters, whose non-lipolytic activity is inhibited by THL. A 
detailed quantitative time-course study further validated lipH as one of the THL 
targets down-regulated during NRP and revived within a day of regrowth. In addition, 
we propose that lipH might provide carbon source to energy-deficient mycobacteria 
resuscitating from NRP by acting on free-esters and may serve as a potential new drug 
target specifically targeting mycobacteria re-emerging from a NRP state. 
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1.1 Biology of Mycobacteria 
1.1.1 Tuberculosis: the disease  
 Tuberculosis (TB) is a leading infectious disease worldwide. In 2010, WHO 
reported 8.8 million new TB cases and 2 million deaths, majority of which occurred in 
developing nations (Figure 1.1)1. New infections occur at a rate of roughly one per 
second on a global scale. Of these 2 million deaths, about 0.35 million occur in those 
co-infected with HIV2. The emergence of multi-drug resistance and extreme drug 
resistant strains raises concerns of a future TB epidemic. A major objective of ongoing 
drug discovery efforts is to shorten chemotherapy from current 6 months to 2 months 
or less. 
 TB is caused by various strains of mycobacteria, most commonly by 
Mycobacterium tuberculosis (Mtb) (see section 1.1.1.1). The disease is transmitted 
through aerosols, by coughing, sneezing or from saliva of infected person and 
typically infects the lungs. One third of the world's population is believed to have been 
infected with Mtb. Most infections are asymptomatic and latent, but about one in 10 
latent infections eventually progresses to active disease, which, if left untreated, kills 
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more than half of those infected. Immune-suppressive triggers such as HIV infection, 
significantly increase this risk3. 
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Figure 1.1. Estimated TB incidence rates, 2010. Source: WHO, Global Tuberculosis 
control 2011. 
 
1.1.1.1 Mycobacterium tuberculosis 
 Mtb is an actinomycete in the genus Mycobacterium, and is closely related to 
saprophytic bacteria such as M. smegmatis, but has altered its genetic structure 
specifically to infect humans. Unlike most gram-positive bacteria, mycobacteria are 
detected using acid-fast staining method because of the unusual waxy coating on their 
cell surface, which makes the cells impervious to Gram staining4. The lipid features 
and composition of mycobacterial cell wall will be discussed in detail in section 1.1.8. 
 Morphologically, Mtb is a non-motile rod cell with a variable size between 0.2-
0.6 µm wide by 1-10 µm long. Mtb has circular chromosomes about 4 million base 
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pairs long, with 65% of G + C content. The genome of Mtb was studied using the 
virulent laboratory strain M. tuberculosis H37Rv. The genome contains 3959 genes, of 
which roughly 40% have been functionally characterized, with another 44% with 
probable postulated function. The mycobacterial species within the ‘Mtb complex’, 
which refers to a genetically closely related group of Mycobacterium species that can 
cause tuberculosis, show 95-100% genome homology based on sequence homology 
studies5. 
 
1.1.2 History of mycobacteria 
 TB is an ancient disease and has claimed more lives than nearly anything else 
in the history of humanity. The timeline of disease extends as far back as recorded 
history. The oldest known example of TB was found in the tubercular decay in the 
spines of an Egyptian mummy dating back five millennia6,7. The TB discovered was a 
bovine form, showing that the disease has accompanied mankind since we started 
domesticating cattle. In the earliest known records, the disease had been commonly 
referred to as ‘phthisis’, or consumption. The latter term, in particular, was introduced 
by Hippocrates, who described the experience of the sufferer as appearing to have 
their lung, almost literally consumed by the disease before it eventually killed them6. 
 In 1769, Franciscus dele Bo Sylvius was the first to define the stages of 
consumption as tubercles, cavities and abscesses in his Opera Medica. Physician 
Benjamin Martin in his A New Theory of Consumption (1790) hypothesized that small 
living creatures that are transmitted through the air causes TB to other patients. In 
1854, a botanist named Hermann Brehmer presented his doctoral dissertation called 
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Tuberculosis is a Curable Disease. In 1865, a French military doctor, Jean-Antoine 
Villemin, demonstrated that the disease could be transmitted between humans to 
cattle, and from cattle to rabbits8. This was a remarkable breakthrough, because 
medical theory still held that each case of consumption arose spontaneously in 
predisposed people. A few years later, in 1882, Robert Koch demonstrated 
conclusively that a bacterial infection caused TB and later investigations proved that 
air and secretions expelled from consumptive lungs contained live bacteria9,10. It was 
not until 1944 that Selman Waksman discovered a usable cure called streptomycin, 
that formed the basis for most medicines we use today11,12. 
 
1.1.3 Diagnosis of TB 
 The most recommended and ancient TB diagnosis tool is multiple sputum 
culture of clinical sample (e.g., sputum, pus, or a tissue biopsy) followed by 
microscopic examination for acid-fast bacilli. However, because of the slow-growth 
rate of Mtb, diagnosis can take about two to six weeks. Another, basic and inexpensive 
way of TB diagnosis is merely based on signs and symptoms, but the diagnosis could 
be challenging in immune-compromised patients like HIV. A chest X-ray is another 
useful TB diagnostic test with its own limitations. On the other hand, interferon-γ 
release assays (IGRAs) and tuberculin skin tests are of little use in the developing 
world, due to the associated costs and false positive results because of population 
neutralization towards environmental mycobacteria13,14. Nucleic acid amplification 
tests are not recommended routinely and blood tests to detect antibodies are not 
recommended due to their non-specificity or insensitivity. Mantoux tuberculin skin 
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test, where individuals are screened by intradermal injection of Mtb PPD for latent 
TB15,16 is also used, but individuals that have been previously immunized with bacillus 
Calmette–Guérin (BCG) may have a false-positive test result. Therefore, a combined 
diagnosis with IGRAs on a blood sample is recommended in those who are positive to 
the Mantoux test17,18. 
 
1.1.4 Prevention and treatment of TB 
 TB prevention primarily depends on the vaccination of infants and also the 
detection and appropriate treatment of active cases. The only currently available 
vaccine is BCG, which is effective against disseminated disease in childhood but 
confers inconsistent protection against contracting pulmonary TB19.  
 The major hurdle in developing anti-TB drugs is due to its complex and rigid 
outer membrane composition, which hinders the entry of drugs, thereby making many 
antibiotics ineffective. Current TB drugs are mainly effective against growing 
mycobacteria and ineffective against latent bacilli20. As of 2010, the recommended 
treatment for active TB is minimum six months of a combination of four antibiotics 
containing rifampicin, isoniazid (INH), pyrazinamide (PZA) and ethambutol (EMB) 
for the first two months, followed by only rifampicin and isoniazid for the last four 
months (Figure 1.2)21. The mechanisms of action of these drugs are reported to be via 
three major ways: 1) bactericidal action: ability to kill actively growing bacilli 
rapidly22. 2) Sterilizing action: ability to kill persisters23 and 3) prevention of 
emergence of bacillary resistance to drugs. 
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 INH, since its discovery, is the most efficient anti-TB agent. INH, a 
nicotinamide analogue, chemically consists of a pyridine ring with a hydrazide group. 
The success of INH is due to its permeability through the rigid mycobacterial 
membrane24. INH is a pro-drug and once inside the mycobacteria, the active form is 
reported to target numerous essential biosynthetic pathways. The bactericidal activity 
is reported to be due to inhibition of mycolic acid biosynthesis gene product inhA25,26. 
 Rifampicin is a broad spectrum antibiotic first identified in 1957. Although 
rifampicin is an inferior anti-mycobacterial drug compared to INH, but in combination 
with other standard anti-TB drugs, the duration of TB chemotherapy regime has been 
reduced from 18 to 9 months27. Rifampicin is a potent sterilizing agent that acts on 
persistent bacilli. Chemically it is composed of an aromatic core linked by aliphatic 
chains. This lipophilic chemistry of rifampicin enables it to easily penetrate through 
the mycobacterial cell wall and its bactericidal activity involves inhibition of the 
transcription enzyme, DNA-directed RNA polymerase28. 
   Inclusion of PZA as an anti-TB drug has led to a further slash in the duration 
of chemotherapy regime from 9 months to 6 months29. PZA has a potent sterilizing 
activity with a unique ability to target semi-dormant bacilli population within an acidic 
environment30. PZA is an amide derivative of pyrazine-2-carboxylic acid, which 
resembles INH structurally. After six decades of anti-mycobacterial activity, its 
mechanism of action was recently shown to block trans-translational mechanism by 
inhibiting rpsA gene product31. 
 EMB, along with three other anti-mycobacterial drugs, constitutes the modern-
day short-course for the treatment of drug-susceptible TB. Like INH, EMB kills 
actively multiplying bacilli and has very poor sterilizing activity. The primary effect of 
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EMB is shown to be towards arabinogalactan biosynthesis through inhibition of cell 
wall arabinan polymerization32. 
 
Figure 1.2. Chemical structure of first-line anti-mycobacterial drugs. 
 
1.1.5 Life cycle of Mtb 
1.1.5.1 Infection stage 
 The progression of Mtb infection is divided into four stages (Figure 1.3) based 
on observations made in animal models as well as in human infections. The 
mycobacterial infection is initiated when the infected individual exhales the pathogen 
in the form of aerosol droplets during coughing, sneezing, spitting or even while 
talking. Each sneeze can release up to 40,000 droplets and it has been anticipated that 
a single bacilli is enough to cause TB. These droplets are small enough to be airborne 
for several hours. A person with active and untreated TB may infect 10–15 (or more) 
people per year33. 
  
1.1.5.2 Immune activation stage 
 Once the inhaled tubercle bacilli reach the lungs, they are phagocytosed by 
alveolar macrophages. The macrophages then invade the subtending epithelial layer, 
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which induces a localized inflammatory response that leads to recruitment of 
mononuclear cells from neighboring blood vessels in order to confine and diminish the 
pathogen34. From the mycobacterial point of view, however, these immune cells serve 
as fresh hosts for the expanding bacterial population and building blocks of a highly 
organized cellular structure, termed granuloma or tubercle, which is a major 
histopathological signature of TB35. This granule-like structure signifies immune-
mediated containment of the infection, which either leads to sterilization of the 
infection or localized caseation and liquefaction that climaxes in the release of 
infectious bacteria into the airways36. 
 
1.1.5.3 Latency stage 
 The granuloma formation limits the dissemination of infection and regulates 
the environment to which Mtb is exposed. Studies have documented these 
environmental changes at the level of infected cells by histochemical studies of 
infected tissue from TB patients and (or) by altering the laboratory growth 
conditions37. Apart from the stress exerted by cytokine response, the bacteria also 
encounter low pH, low oxygen and low nutrition stress38. The low pH is induced 
within macrophages by fusion of mycobacteria containing phagosomes with the 
lysosomal compartment. The low oxygen (or hypoxic) and low nutrition stress are 
provoked due to poor perfusion of the granuloma core, which is enclosed by the 
mixture of dead and activated immune cells39,40. Under these unfavorable conditions, 
pathogenic Mycobacterium spp. can arrest its growth, trigger a metabolic downshift 
and undergo a state of dormancy – a non-replicating state characterized by low 
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metabolic activity and phenotypic drug resistance. The pathogen can prevail in this 
state for a few days up to several decades. At this stage there are no overt signs of 
disease and the infection is under immune-mediated control41. 
 
 
Figure 1.3. Life cycle of Mtb. Mtb infection follows a well-defined sequence of 
events, which can be divided into four stages, infection, immune activation, dormancy 
and regrowth or reinfection. Picture adapted from Russell et al. 201042. 
 
1.1.5.4 Reactivation/resuscitation 
 The non-replicating mycobacteria under the state of dormancy do not pose 
much of a threat if they are unable to regrow or resuscitate. Resuscitation is the final 
stage of mycobacterial life cycle involving the reversal of non-replicating bacilli into a 
ways (6). Modern imaging observations on human
TB stress that the balance between containment
and disease progression is complex and highly
dynamic and appears to be a local phenomenon
involving differential progression of individual
granulomas within a single individual (7).
Immune Protection Through Vaccination
A preexisting, specific immune response against
Mtb, acquired through vaccination or a chemo-
therapeutically resolved infection, has an impact
on the course of TB (8) (Fig. 2). The immune
host is not protected against infection, but pro-
gression to containment occurs earlier, and at a
lower bacterial load. In most animal models,
bacterial containment is achieved with 1/10th
as many bacteria as would be found in the lungs
of a naïve animal. At the human population level,
this would make a substantial difference, be-
cause progression to disease is linked directly to
bacterial load. If disease is determined at the
level of the individual granuloma, then the pres-
ence of fewer granulomas may reduce the chance
of developing active disease.
Although the contribution of antimicrobial
effectors has been established in mice (9, 10),
the relative hierarchy of immune-mediated kill-
ing mechanisms in humans is unclear. However,
from the increased susceptibility of HIV+ hu-
mans, we infer that CD4 T cells are important in
the control of human TB. Similarly, the use of
tumor necrosis factor (TNF)–neutralizing agents
for treatment of inflammatory diseases substan-
tially increases the risk of TB, which suggests
that the level of this cytokine is critical to the
balance between disease control and pathology
(11–14). From these data and studies of genetic
mutations that predispose humans to TB (15),
we infer that, similarly to mice, macrophage
activation in humans is central to the control of
infection.
BCG: It’s Not for Everyone
Bacillus Calmette-Guérin (BCG) is the only ap-
proved vaccine against TB. It was developed
though the serial in vitro passage of M. bovis
until it became nonpathogenic. It is used in
countries with endemic TB because it protects
children against severe forms of disease, such as
TB meningitis or disseminated infection. How-
ever, although effective against development of
TB in some countries such as the United
Kingdom (16), its efficacy has been questioned
in several studies, most notably in India, where
very limited (or no) protection has been re-
ported (17). There are three main hypotheses
as to why BCG works in some populations but
not in others. First, BCG has become too atten-
uated through culture, and modern preparations
of the vaccine are too benign to generate ade-
quate protective immunity (18). Second, expo-
sure of infants to environmental mycobacteria
in countries like India could lead to tolerance
(19–21) or, third, clearance of the BCG in some
populations may occur before development of
a protective immune response. Clearly, as we
move forward with new vaccine constructs, it
is vital that we better understand the limitations
of BCG-induced protection, so that a new vac-
cine can be effective in those countries where it
is most needed.
New anti-TB vaccination strategies can be
divided into three broad categories. First, improv-
ing BCG by adding or overexpressing strongly
immunogenic Mtb antigens, which would enhance
and broaden the immune responses induced by
the recombinant bacterium (22–24). Second, at-
tenuating strains of Mtb through the deletion of
genes for specific metabolic pathways required
for survival or full virulence (25–27). And third,
the use of prime-boost strategies that direct and
amplify an initial “protective” immune response
through subsequent inoculation with viral vec-
tors encoding Mtb antigens or protein subunits
(28–33).
However, if the protective immune response































Fig. 1. The life cycle of M. tuberculosis. The infection is initiated when Mtb bacilli, present in exhaled
droplets or nuclei, are inhaled and phagocytosed by resident alveolar macrophages. The resulting
proinflammatory r sponse triggers the infected cells to invade the subtending epithelium. This response
also leads to the recruitment of monocytes from the circulation, as well as extensive neovascularization of
the infection site. The macrophages in the granulomas differentiate to form epithelioid cells, multinucleate
giant cells, and foam cells filled with lipid droplets. The granuloma can become further stratified by the
formation of a fibrous cuff of extracellular matrix material that is laid down outside the macrophage layer.
Lymphocytes appear to be restricted primarily to this peripheral area. Many of the granulomas persist in
this balanced state, but progression toward disease is characterized by the loss of vascularization,
increased necrosis, and the accumulation of caseum in the granuloma center. Ultimately, infectious bacilli
are released into the airways when the granuloma cavitates and collapses into the lungs. [Adapted with
permission from Macmillan Publishers Ltd. (3)]
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state of metabolically active growing population. Reactivation of infection is a result 
of poor immune surveillance generally as a consequence of malnutrition, old age or 
HIV infection43. Resuscitation is achieved when the center of granuloma loses its 
vascular appearance, becomes necrotic and caseous. This progresses with breakdown 




 Granuloma formation is a hallmark event in TB infection and its formation is 
mediated by both innate and acquired immune responses, and bacterial cell wall 
components such as trehalose dimycocerosate (TDM, also known as cord factor)47. 
Granuloma formation is initiated by recruitment of immune cells to the site of 
infection by range of cytokines and chemokines that are released in response to the 
infection. Among the cytokines, tumor necrosis factor (TNF)-α plays a dominant role 
by elevating the production of the chemokines. The granuloma is a complex structure 
composed of infected macrophages surrounded by lipid droplet (LD) loaded foamy 
macrophages and other mononuclear phagocytes. The periphery of the granuloma has 
a layer of lymphocytes in association with a fibrous cuff of collagen and other 
extracellular  matrix components (Figure 1.4).  
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Figure 1.4. Granulomas containing infected macrophages are regions of Mtb 
persistence and pathology. The caseous core is composed mainly of necrotic tissue 
surrounded by foamy macrophages with a layer of activated macrophages and T-
lymphocytes42. Picture adapted from Cotes et al. 200848. 
 
 In humans, granulomas are distinguished into three major forms: solid 
granulomas, necrotic granulomas and caseous granulomas49. Solid granulomas are 
highly structured, early-stage granuloma that confines mycobacteria that are in a non-
replicating and low metabolic state, while the necrotic granuloma is a more mature 
granuloma with necrotic cells at its core. Histo-chemical studies have reported low 
oxygen tension at the core of the granuloma, with predominant non-replicating 
persistence bacilli50. Caseous granulomas are the final stage of bacilli confinement in 
which the structure wanes as the core forms a cavity and oxygen tension is retained. 
This provokes resuscitation of dormant bacilli, which probably utilize caseous debris 
as a nutrient source. Finally, the structure disintegrates and bacilli spread to other 
tissues and organs. 
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1.1.7 Survival strategies in the host 
 Once the Mtb is engulfed by alveolar macrophages, the pathogens are confined 
inside a phagosome. However, Mtb manages to overcome eradication by arresting the 
normal progression of phagosome, by restricting the acidification and preventing the 
fusion of phagosome with pre-formed lysosomes. Several studies have reasoned that 
the unique composition of cell wall and other bacterial effectors modulate the 
phagosome function. This was further verified by the analysis of exosomal fraction 
showing the presence of peripheral lipid species51-55 and certain secretory proteins56,57. 
 In the phagosome, Mtb encounters a range of microenvironments, to which the 
pathogen has to realign its metabolism to assure survival. The nature of the 
phagosomal environment has been proposed to be nitrosative, oxidative, hypoxic, low 
pH and with limited nutrient supply38,49. Additionally, genome-wide microarray 
techniques to study Mtb’s transcriptional response have shown that one set of genes 
that was observed to be up-regulated involves lipid metabolism, suggesting that lipids 
are important for Mtb virulence and survival58,59. In addition, the up-regulation of 
glyoxylate pathway genes illustrates that fatty acids represents exclusive carbon 
source. Mtb has been shown to metabolize host-derived cholesterol as a carbon 
source60,61. Recent data have also demonstrated that Mtb residing in phagosomes 
utilize triacylglycerols (TAGs) from the host cells to be stored in the form of 
intracellular LDs62,63. This was further supported by the observation made in in vitro 
NRP culture model, where resuscitation of NRP bacilli caused utilization of stored 
neutral lipids64-66. The catabolism of these lipid funnels into propionyl-CoA, a C3 
intermediate, which is toxic in excess. However, propionyl-CoA toxicity can be 
avoided by processing it through the glyoxylate shunt pathway, which generates 
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required energy for dormant bacilli49,59,67,68. Globally, the current understanding 
suggests that mycobacteria modulate the host activity and also utilize host lipids for 
survival. 
 
1.1.8 Lipids in mycobacterial survival 
 In Mtb, 30% of the genome codes for genes involved in lipid metabolism, of 
which 250 genes are involved in fatty acid metabolism and 39 are involved in the 
polyketide metabolic pathway that generates the unique mycobacterial lipids69. Such 
enormous dedication and conservation of genes towards lipid metabolism shows the 
biological and evolutionary importance of the waxy coat to pathogen survival.  
 Mtb possesses a rigid cell wall that prevents passage of nutrients into the cell, 
therefore giving it the characteristic of slow growth rate. The cell envelope contains a 
polypeptide layer and a peptidoglycan layer, which are decorated with complex 
polyketide lipids such as mycolic acids (Figure 1.5). The Mtb cell wall contains three 
classes of mycolic acids: alpha-, keto- and methoxy-mycolates. The cell wall also 
contains lipid complexes including acyl glycolipids, free lipids and sulfolipids70. The 
porins embedded in the outer membrane facilitate transport of selective compounds. 
Beneath the mycolic acid layer, there are layers of arabinogalactan and peptidoglycan 
that lie just above the plasma membrane71. 
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Figure 1.5. Mycobacterial cell wall is a highly complex structure. The 
mycobacterial cell wall provides a potent permeability barrier, and its components 
play an important role in bacterial virulence and pathogenicity. The wall contains 
long-chain polyketides such as, mycolic acids that are covalently linked to 




 During infection, the intracellular mycobacteria actively shed cell wall 
components extending the influence of the bacterium. Reports have demonstrated the 
impact of secretory peripheral cell wall lipids on bacterial colonization and 
persistence. Notably, defects in TDM, phthiocerol dimycocerosate (PDIM) or 
cyclopropanated mycolic acids showed marked bacterial attenuation within the 
lungs72-75. Studies have also shown that these bioactive lipids are overproduced by 
intracellular bacilli, and consolidate in the internal vesicles that are subsequently 
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exocytosed into the extracellular milieu54,76. The most bioactive component of these 
released lipids is TDM77,78, as recent reports have shown that the oxygenated mycolic 
acids present in TDM are stimulators of Toll-like receptors, which then induce the 
foam cell formation in Mtb-infected macrophages79-81. 
 Foamy macrophages can be extremely abundant within TB granulomas and the 
conversion of macrophages into foam cells occurs due to dysregulation in the balance 
between the influx and efflux of low-density lipoprotein (LDL) particles from the 
serum82. The LDL contains cholesterol, TAGs and phospholipids, and although most 
of the phospholipids and TAGs are metabolized, the cholesterol is retained by the 
macrophage mainly in an esterified form. The esterified cholesterol is either 
sequestered into LDs or pumped out of the cell. 
 In vitro studies have shown that human macrophages under hypoxic conditions 
form foamy lipid droplets and Mtb-infected human alveolar macrophages are also 
shown to be highly enriched in LDs. Electron microscopy has revealed Mtb in close 
proximity to the intracellular LDs, and it has been postulated that this might be a 
privileged site that would support growth of persistent bacteria within the granuloma81. 
Recent studies have shown that the host lipids can act as the precursors for these 
accumulated neutral lipids63,66,83. Within the foamy macrophages, phagocytosed 
bacteria preferentially metabolize these lipids as a carbon source, a view that is 
supported by evidence of up-regulation of several mycobacterial genes involved in 
lipid metabolism62,84. The processing and the by-product detoxification were discussed 
in section 1.1.7 and the biology of mycobacterial intracellular LDs are discussed in 
detail in section 1.3.1. 
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1.2  Mycobacterial metabolic stages 
1.2.1  Definitions of dormancy, persistence and latency 
 Mtb has the remarkable ability to reside in human tissues in a state of non-
replication for days up to several decades. Several groups have defined the non-
replicating state of tubercle bacilli with several terminologies such as dormancy, 
latency or persistent state. 
 Dormancy may refer to the organism when it is metabolically inactive. In this 
state mycobacteria possess no or low metabolic activity, with no colony forming 
capability when cultured on agar plates85,86. The most important feature of a dormant 
bacillus is its ability to resuscitate from dormancy under favorable conditions. Overall, 
the appropriate definition of dormant bacilli is their ability to form colonies when 
resuscitated from the metabolically inactive state. The molecular basis of dormancy is 
poorly understood due to lack of appropriate experimental dormancy models87. 
 Mycobacterial persistence is a phenomenon where drug-susceptible 
mycobacteria survive indefinitely within mammalian host despite continuous exposure 
to appropriate antibiotic(s). Although, from the host point of view the persistent and 
dormant bacilli may mean the same, the main distinction in experimental models is the 
colony forming capability (colony forming unit, CFU) of persistent mycobacteria 
compared to dormant bacilli. In this state, the bacilli have the capacity to form CFU on 
a plate88. 
 Latency refers to the clinical observation of infection without disease 
symptoms. Latency is an in vivo steady-state situation established between pathogen 
and host, therefore it does not specify the metabolic or growth status of bacilli. The 
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non-symptomatic latency state could be established due to two major outcomes, either 
a host immune-mediated control of small number of bacilli or a non-replicating state 
established by the bacilli89. 
 
1.2.2  Generation of dormant bacilli 
 Although current studies of mycobacterial biology have shown the existence of 
non-replicating dormant bacilli in the human host, the metabolic conditions that dictate 
the formation of dormant bacilli are poorly understood. The primary reason for this is 
the lack of animal models to generate dormant bacilli and secondly because of the 
technical difficulties associated with isolation of dormant bacteria from a 
heterogeneous bacterial population containing live and dead bacteria87. Factors such as 
hypoxia and nutrient deprivation in the caseous lesions of granuloma core could 
induce or facilitate the formation of dormant cells. Generation of anti-bacterial nitric 
oxide and related radicals by activated macrophages further regulates the bacterial 
growth90. In addition, other factors such as aging, temperature, and pH expedite the 
formation of dormant cells in bacterial populations91. 
 
1.2.3  Laboratory model for generating dormant bacilli 
 Several studies have reported direct and indirect evidence for the existence of 
non-replicating dormant mycobacteria in human hosts50,92,93, but the most credible 
evidence was demonstrated by experimental generation of NRP bacilli under various 
stress conditions. Analysis of these dormant mycobacterial cells at genomic, proteomic 
and metabolic levels has further assisted in understanding the biology of latent 
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mycobacteria. In the next section, I have discussed some of the models for generation 
of non-replicating dormant mycobacteria. 
 
1.2.3.1 Animal models 
 Animal models are best suited to study the biology of latent TB and also test 
the drug efficacy towards the disease. In the Cornell mouse model, animals are 
infected with excessive dose of Mtb and then treated with anti-mycobacterial drugs for 
a defined time period. The infected mice that possess no cultivable bacilli are then 
subjected to immunosuppressive drugs, to reactivate the infection through recurrence 
of resistant tubercle bacilli. Although mice are the most widely used animal models for 
drug discovery, in the case of TB, mice do not recapitulate human pathology78,79. 
 In contrast, the rabbit model of latent TB contains persistent and host-
contained infection that can be reactivated by immunosuppressive agents. Although 
the model needs to be validated using anti-TB drugs, it is currently the most appealing 
TB model to evaluate drug efficacy94,95. Non-human primate (macaques) latent models 
are proposed to possess the TB pathology and clinical characteristics similar to 
humans. Histological study has validated thick fibrous mass with caseation and a 
hypoxic environment96,97 and the model was recently validated using Metronidazole 
drug 98. 
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1.2.3.2 In vitro dormancy model 
 An in vitro dormancy model generates NRP mycobacteria in a stress 
environment that mimics the bacilli survival inside lung lesions. Reduced oxygen 
tension, nutrient limitation (carbon and nitrogen), acidic pH, and high carbon dioxide 
are among the major stress-factors that were considered to drive bacilli in a state of 
dormancy99,100. Some of these stresses have been applied to Mtb in attempts to 
generate a dormancy-like state in vitro. 
 The two main in vitro models to generate non-replicating bacilli are based on 
oxygen and nutrient starvation. An in vitro model of hypoxic dormancy called Wayne 
model, mimics the hypoxic environment inside the granuloma. This model will be 
discussed in detail in next section. The other mycobacterial NRP model is nutrient 
deprived, oxygen rich NRP model101. This model mimics the nutrient limitation that 
the dormant bacillus overcomes in host macrophages. In this model the actively 
growing mycobacterial cultures are starved in distilled water and then can be 
resuscitated in nutrient-rich medium after several days to weeks102-104. 
 The above-mentioned in vitro models are highly simplified single stress NRP 
models, compared to the numerous stresses that mycobacteria overcomes inside 
granuloma. Interestingly, a recent publication on multi-stress dormancy model, where 
mycobacteria was exposed to low oxygen (5%), high CO2 (10%), low nutrient (10% 
Dubos medium) and acidic pH 5.0, could perhaps have better presentation of dormant 
bacteria compared to other single stress in vitro models. The reproducibility and yield 
of the multiple stress-model still needs to be validated83. 
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1.2.3.3 The Wayne model: Hypoxia-induced NRP 
 Mtb overcomes low oxygen tension or hypoxic stress during its survival in 
poor perfusion environment inside the macrophage, granuloma or caseous lesion. An 
in vitro NRP model called the Wayne model was established partially imitating this 
environment. In this model, the logarithmic state (or exponentially growing) 
mycobacterial cultures are subjected to a gradual depletion of oxygen to micro-
aerophilic condition and ultimately, anaerobic conditions in the culture medium105,106. 
Experimentally, the model relies on a self-generated oxygen gradient, where aerobic 
mycobacteria are incubated in sealed culture tubes with a defined culture-to-headspace 
ratio (HSR) and with gentle stirring. Overtime mycobacteria in the culture utilize the 
oxygen in the tube, shut down its metabolic activity and gradually transition to the 
NRP state107. However, the NRP bacilli generated in the Wayne model have the 
capability to reactivate when fresh oxygen is provided and were shown to be resistant 
to conventional antimycobacterial agents108. The significant advantages of this model 
are its well-defined parameters and reproducibility. Apart from Mtb, this model is 
already employed in other Mycobacterium spp, such as M. bovis BCG66,109 and M. 
smegmatis110,111. This model has its own limitation in the over-simplifying a complex 
range of environmental stimuli that bacilli experience in the granuloma. 
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Figure 1.6. Mtb hypoxia-induced NRP model shows three different metabolic 
stages. The in vitro culture NRP model growth curve represents three metabolic states 
(separated by arrows): logarithmic, NRP-1 and NRP2, which were driven by oxygen 
saturation in the culture. Picture adapted from Wayne et al. 1996112. 
 
 The Wayne model can be differentiated into two metabolic (NRP) stages 
(Figure 1.6). In NRP-1 stage, a micro-aerophilic environment is generated due to 
declining oxygen saturation of ~1% and a stage-characteristic constant ATP 
generation. In comparison, mycobacteria in NRP-2 prevail at anaerobic conditions 
(~0.06% oxygen saturation level). The bacterium at this stage has very low metabolic 
activity, with no protein synthesis but is responsive to heat shock and the bacterial 
viability remains unchanged113. The NRP-2 stage is characterized by bacterial 
susceptibility towards metronidazole, an aerobic bactericidal agent, but in mouse
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models, metronidazole has little or no activity. Although this is a major drawback of 
the Wayne model, it is still a well-studied mycobacterial NRP model and has led to the 
identification of several factors such as isocitrate lyase (ICL) and glycine 
dehydrogenase that are related to persistence in vivo. In addition, the model has helped 
to generate and study in detail the expression of the dormancy regulon, a dosR-
dosS/dosT two-component response regulator of mycobacterial dormancy114,115. 
 
1.2.4 Lipids: an alternative energy source 
 The tubercle bacillus was long considered to be an aerobic organism with its 
metabolism highly dependent on oxygen. But in a non-perfusion intracellular milieu, 
mycobacteria encounter a nutrient-deprived, hypoxic environment. In order to 
circumvent these stress factors, mycobacteria developed an alternative mechanism for 
generating energy116. 
 Lipids play a key role in mycobacterial survival and pathogenicity, which is 
evident from 30% of its genome dedication towards lipid metabolism. The 
unavailability of carbohydrates and accumulation of neutral lipids in and around 
dormant mycobacteria suggests that lipids may serve as an alternative carbon source 
during dormancy81,117. Developments in the field of imaging, gene-microarray59,118, 
proteomics84 and biochemical analyses66,119 have further validated neutral lipid 
accumulation and utilization in mycobacteria under the non-replicating persistent state. 
In addition, similar analysis35,81,120 of lung granulomas has shown neutral lipid 
accumulation in macrophages (foamy macrophages) as discussed previously in section 
1.1.5. A recent in vitro biochemical study showing host lipids being transported and 
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accumulated in mycobacteria during NRP stage further validates the importance of 
lipids in mycobacterial dormancy63. Although the origin and accumulation of these 
lipids under in vitro conditions is well studied64, their utilization mechanism and the 
enzymes involved are poorly understood, due to complexity at genetic and 
metabolomics levels, and understanding this might prove useful for drug discovery 
towards dormant bacilli. 
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1.3 Mycobacterial lipid metabolizing genes 
1.3.1 Lipid droplets: The energy store house of dormant bacilli 
 Mycobacterial species possess a large number of chemically diverse lipids in 
their cell envelope. Some of these lipids, especially polyketides, glycolipids, 
lipoglycans have been the focus of extensive research and are considered as major 
virulence determinants in mycobacterial infection121,122. In spite of several chemical, 
biological and biosynthetic studies, the complex architecture of the mycobacterial cell 
wall remains puzzling.  
 In contrast, the intra-cytoplasmic lipids have been largely neglected, until the 
link between intracellular lipids and mycobacterial survival was recognized. 
Numerous studies have shown the accumulation of intracellular lipid inclusion bodies 
(or lipid droplets, LDs) in dormant states of animal models and in vitro culture 
models63,93,123. Direct and indirect evidences have shown that host lipids are the 
probable precursors for mycobacterial LD lipids63,124,125. Recent reports from the 
Wenk’s group and several other groups have shown the lipid composition of LDs, 
which are enriched in TAGs, cholesterol esters and phospholipids (Figure 1.7)59,62-
65,81,119,126. In addition, these stored TAGs are utilized as a carbon source during 
resuscitation of in vitro dormant cultures66. 
 The biology of TAG accumulation and utilization is not limited to Mtb, but 
have also been reported for other mycobacterial species, such as M. bovis BCG64,66, M. 
leprae127 and M. smegmatis119,123. Although a loose link between intra-cellular lipid 
accumulation, utilization and mycobacterial persistence has been established, 
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identification of these lipid metabolizing genes and development of novel drug targets 
might be a viable option of combating Mtb in latent phase infection83. 
 
 
Figure 1.7. Composition of lipid droplets. Mtb accumulate and utilize intra-cellular 
lipid inclusion bodies during entry and exit from dormancy respectively. Picture 
adapted from Krahmer et al., 2009128. 
 
1.3.2 Lipases and esterases 
 The International Union of Biochemistry has numerically classified enzymes 
(Enzyme Commission, EC) based on the chemical reaction they catalyze. Among the 
six enzyme families, hydrolases (EC 3) are enzymes that act on a wide range of 
substrates to form products via hydrolysis. Hydrolases have been further classified into 
several subclasses, based on the bonds they act upon (ester, peptide, amide, etc.). Ester 
hydrolases, also called esterases (EC 3.1), are a diverse group of hydrolases widely 
distributed in animals, plants, and microorganisms. Esterases catalyze the cleavage 
and formation of ester bonds and based on the nature of the ester bonds, esterases have 
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been further sub-classified into various groups (Figure 1.8). Among them, 
carboxylester hydrolases (EC 3.1.1) and thioester hydrolases (EC 3.1.2) are enzymes 
that hydrolyze carboxylic esters and thioesters. The substrates of these carboxylester 
hydrolases (EC 3.1.1) are esters derived from the condensation of a carboxylic acid 
and an alcohol. Traditionally, members of carboxylester hydrolases (EC 3.1.1) have 
been classified into two major subclasses on the basis of their known substrate 
specificity: carboxylesterases (EC 3.1.1.1) and lipases (EC 3.1.1.3)129.  
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1.3.2.1 Non-lipolytic esterases 
 Carboxylesterases (EC 3.1.1.1) are non-lipolytic hydrolases, which act on a 
wide variety of structurally diverse water-soluble ester molecules. They hydrolyze 
carboxylic ester substrates in the presence of water to form two products, an alcohol 
and a carboxylate product. Although the enzyme is widely distributed in nature, its 
metabolic function is unclear; several groups have proposed that they play important 
roles in drug metabolism and detoxification130,131. Studies have also reported that 
carboxylesterases catalyze lipid derivatives such as short- and long-chain 
acylglycerols, acyl-CoAs and acylcarnitine132,133. Most enzymes from this group are 
structurally conserved with α/β-fold core structure (Figure 1.9A) (except β-lactamase-
like proteins), which we will further discuss in section 1.4.1. Some of them also 
possess serine in their active site, therefore also called serine hydrolases, which 
includes chymotrypsin and acetylcholinesterase134,135. For our convenience, non-
lipolytic carboxylesterases henceforth will be simply referred to as esterases. 
 
1.3.2.2 Lipolytic esterases 
 Lipases (EC 3.1.1.3) are lipolytic enzymes, which constitute a special class of 
esterases capable of releasing fatty acids from natural water-insoluble esters (lipids), 
as opposed to non-lipolytic enzymes. Lipids are in-fact a group of structurally 
heterogeneous natural metabolites that are insoluble in water but soluble in apolar and 
slightly polar organic solvents. Lipases display specificity and maximal activity 
towards water-insoluble long-chain lipid substrates with glycerol backbone, such as 
TAGs129,131. The physico-chemical character of the substrate constitutes the main 
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property that distinguishes lipases from esterases. Despite different biochemical 
properties and physiological functions, the sequence and structural homology studies 
has revealed remarkable similarities between lipases and esterases136. The availability 
of crystal structure has aided in comparison of lipases and esterases to show that both 
groups have a highly conserved α/β-fold core structure (Figure 1.9B)137-139. 
 
1.3.2.3 Hormone-sensitive lipases (HSL) 
 Apart from classifying carboxylester hydrolases (EC 3.1.1) on the basis of their 
substrate specificity, an alternative classification has been proposed based on their 
sequence homology (Figure 1.9C)140. In this classification, a third group, HSL, was 
proposed apart from esterases and lipases. HSL were first reported to increase upon 
exposure to adrenaline or adrenocorticotropic hormones in mammalian tissues141, 
thereby, the name hormone-sensitive lipase and classified as EC 3.1.1.79. HSL are 
lipases that display broad substrate specificity, hydrolyzing long-chain TAG, 
diacylglycerol (DAG), and monoacylglycerol (MAG) as well as cholesterol esters and 
retinyl esters. The HSL family includes both mammalian and several bacterial 
carboxylester hydrolases142-144. Based on biochemical studies, HSL could be 
considered as a cholesteryl esterase as well as TAG lipase145. In humans, HSL are 
encoded by the lipE gene as long and short form of enzyme. The long form is 
expressed in testis with cholesteryl esterase activity and the short form is expressed in 
several other tissues, such as adipose tissues with TAG lipase activity146,147. 




Figure 1.9. Schematic representation of carboxylester hydrolases. 
A. Bacterial esterase. B. Bacterial lipase. C. Hormone sensitive lipase. A typical 
carboxylesterase consists of α/β-fold core with consensus GXSXG motif and catalytic 
triad of active serine (star), aspartate and histidine (arrows). HSL, in addition, contains 
a conserved HGG motif (cross). Adapted from ESTHER database 
(http://bioweb.ensam.inra.fr). 
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1.3.3 Carboxylester hydrolases in bacterial pathogenesis 
 Bacterial pathogens use a wide range of strategies to infect and survive in the 
host. One of the highly conserved strategies is to modify the host response and/or 
utilize host factors for survival and colonization. Thus, identification and 
characterization of these different strategies is key to combating bacterial diseases148.  
 Lipolytic enzymes are fundamental to lipid metabolism. Studies on pathogenic 
bacteria suggested involvement of lipolytic enzymes in virulence and pathogenicity. 
For instance, lipases of Propionibacterium acnes and Staphylococcus epidermidis are 
anticipated to be involved in colonization and persistence of bacteria on the human 
skin149-152. Lipases of Staphylococcus aureus and Pseudomonas aeruginosa are 
produced during the bacterial infection process153. In vitro, Burkholderia cepacia 
secretes a lipase that increases its invasion into epithelial cells without affecting its 
plasma membrane154. Pseudomonas cepacia lipases are a major requirement for 
bacterial virulence155. Phospholipases from bacteria, viruses, and parasites are shown 
to act as virulent factors by modifying host cell lipids. Apart from virulence, lipases 
may also contribute to the infection and bacterial proliferation by causing the 
destruction of the host tissues, thereby supplying hydrolyzed material to the organism 
as nutrients. In many pathogenic bacteria, carboxylester hydrolases are reported to 
hydrolyze esters of glycerol with preferably long-chain fatty acids156. 
 The lipolytic enzymes are also one of the known virulence factors in many 
fungal species such as Candida albicans phospholipases157 and in Alternaria 
brassicicola and Fusarium graminearum158,159. Lipolytic enzymes have also received 
attention in human health as therapeutic agents against obesity and cardiovascular 
diseases, or as adjuvants in treatment of cystic fibrosis or chronic pancreatitis160-162. 
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1.3.4 Lipases and esterases in mycobacteria 
 The mycobacterial lipid catabolizing genes have been categorized into several 
(super)families either on the basis of their sequence homology or domain organization 
(‘Lip family’ genes, HSL, PE/PPE), structural conservation (α/β-hydrolases), substrate 
specificity  (lipases, esterases, cutinases, phospholipases, patatins) or even on the basis 
of their gene expression pattern (stress response, dormancy regulon)156. Two of these 
categories (α/β-hydrolases and ‘Lip family genes) are explained in sections below. 
 
1.3.4.1 α/β-hydrolase superfamily 
 One of the highly recognized structural categorizations of lipid metabolizing 
enzymes are the α/β-hydrolase fold enzymes. These enzymes have a α/β-fold core 
structure besides a consensus GXSXG motif. The canonical α/β-core has eight-
stranded β-sheets (all parallel except β2), with α-helices or small domains between 
each pair of β-sheets. 
 All enzymes in this family consist of highly conserved catalytic machinery 
composed of a nucleophilic serine, charge relay network aspartate and proton carrier 
histidine. The active nucleophilic serine is positioned on the sharp turn after sheet β5, 
the aspartic acid is positioned immediately after sheet β7 and the histidine base is 
located near the C-terminus after β8138,163. Structurally, many members of this family 
contain a loop insertion, known as the ‘lid’, that folds into and covers the catalytic 
active site138. This secondary structural element is key in determining the substrate 
specificity and enzyme activity of the α/β-hydrolases164-166. Although, α/β-fold family 
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enzymes share some features, they differ in their sequence homology and substrate 
specificity. Most members of α/β-hydrolase family are esterases or lipases, but the 
family also includes thioesterases, haloperoxidases, dehalogenases, epoxide 
hydrolases, peptidases, etc.139 167. 
 94 gene products were revealed as members of the α/β-hydrolase fold family 
in Mtb based on the comparative sequence analysis. These are well conserved among 
other mycobacterial species such as M. bovis BCG, M. avium, etc.168. More 
information on the 94 α/β-hydrolases in the M. bovis BCG genome can be found in 
Table 1.1 and Figure 1.10. Numerous gene microarray studies have shown the 
importance of α/β-hydrolase family proteins in mycobacterial lipid metabolism, cell 
wall maintenance, and virulence156,169. Among these annotated lipase and/or esterase 
genes, very few have been structurally and functionally characterized, the major 
hurdle being gene redundancy and protein hydrophobicity. Some of the enzymes 
characterized in α/β-hydrolase family will be discussed in detail in section 1.3.4.3. 
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Table 1.1. List of α/β-hydrolase superfamily proteins in M. bovis BCG 
 




Figure 1.10. Subclassification of mycobacterial α/β-hydrolase superfamily 
proteins. The 94 α/β-fold hydrolases can be subclassfied based on their substrate 
specificity into 7 sub-families. The plot depicts that half of the family possesses 
esterase activity. 
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1.3.4.2 ‘Lip family’ genes 
 Mtb contains 24 putative lipases and/or esterases (in common carboxylester 
hydrolases) annotated as ‘Lip family’ genes (lipC till lipZ). The genes are interpreted 
based on the presence of the α/β-hydrolase fold and consensus sequence GXSXG 
characteristic, but not on the basis of their lipolytic activity. The ‘Lip’ genes are well 
conserved among the slow growing Mycobacterium species, whereas homology search 
indicated the absence of 9 ‘Lip family’ genes in fast growing saprophytic, non-
pathogenic M. smegmatis156. 
 In silico analysis of 24 ‘Lip family’ enzymes (Table 1.2) showed that 20 of 
them had high sequence homology towards α/β-hydrolases, whereas six others (lipD, 
E, K, L, P and X) had better homology towards β-lactamase, with no α/β-fold core 
and GXSXG motifs. Among the 20 lipases/esterases, 8 of them belonged to HSL 
family (lipF, H, I, N, R, T, U, Y) and 2 of them are members of the PE/PPE family 
(lipX and Y) proteins170. 
 Several groups have tried to express, purify and biochemically characterize 
‘Lip family’ genes with modest success, mainly because of poor expression and 
hydrophobicity of the protein. Among the in vitro characterized carboxylester 
hydrolase genes, only two have been functionally characterized and related to 
mycobacterial survival and pathogenicity (section 1.3.5)48,65,169. 
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Table 1.2. List of ‘Lip family’ proteins in M. bovis BCG 156 
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1.3.5 Carboxylester hydrolase in Mycobacterial life cycle 
 Deb et al. (2006) used an E. coli expression system to clone and express all the 
24 Mtb ‘lip family’ proteins. Only lipY (rv3097c) was expressed in abundance and 
they demonstrated the TAG lipase activity of lipY using the recombinant E. coli cell 
lysate. In addition, lipY was also shown to be up-regulated when mycobacteria were 
nutrient starved, suggesting that lipY was acting on stored TAG to provide essential 
energy65,167. BCG1721 (rv1683) is the other mycobacterial protein that has been 
biochemically characterized and functionally related to the mycobacterial life cycle. 
BCG1721 is a LD-associated dual functional enzyme containing acyl-transferase and a 
long chain TAG lipase activity. In addition, BCG1721 is shown to be up-regulated in 
mycobacteria resuscitating from hypoxia-induced NRP64. 
 Canaan et al. (2004) cloned and over-expressed lipH (rv1399c) in E. coli as 
inclusion bodies and using refolded protein, they biochemically characterized the lipH 
gene product as a short-chain carboxylesterase, with preference towards soluble TAGs 
and vinyl esters142,171,172. Similarly, lipF (rv3487c) was cloned and refolded, and 
biochemical assays showed that lipF efficiently hydrolyses phosphatidylcholine (PC) 
to generate DAG173. LipC, a short-chain esterase, is reported to be secretory and 
immunogenic, with preference towards extracellular short-chain esterase174. 
 Numerous non-‘Lip family’ gene recombinant products were also 
characterized biochemically. For instance, an immunogenic rv0183 was shown to be a 
structural component of the mycobacterial cell wall and with reported mono-acyl 
glycerol (MAG) activity the protein perhaps hydrolyzes host lipids124. MT2282 
(rv2224c, caeA) is an α/β-hydrolase with preference towards free substrate in the local 
environment172. In addition, three of the seven Mtb cutinase-like proteins (culp 1-4) 
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are reported to be present in the culture filtrate or membrane fractions with preference 
towards MAG (culp1), phospholipid (culp4 and culp6) and thioester (culp6) 
substrates125,175. The crystal structure of Mtb rv0045c revealed the fine feature of α/β-
hydrolase and in silico approach hypothesized its preference towards short-chain 
esters176. 
 Microarray-based studies have reported up-regulation of certain α/β-
hydrolases during mycobacterial survival under different metabolic stress conditions 
(hypoxia, low pH and nutrient starvation). For instance, lipC, lipU, lipT, lipX and caeA 
(rv2224c) were found to be up-regulated among other genes under nutrient 
starvation104. Similarly, lipF, lipR and lipX were found to be up-regulated under 
conditions of acid-shock177,178. In addition to the stress response, some of the 
membrane exposed and/or secretory lipase/esterase proteins are reported to be 
immunogenic and/or virulent, such as lipC, lipF, lipY, cut2, cut5, rv0183 and caeA 
(rv2224c). The M. avium homolog of lipL was reported to be up-regulated in culture 
macrophages and mice179. Several gene knockout experiments on lipases and esterases 
have provided sufficient evidence on the a role of carboxylester hydrolases and further 
highlighted the importance of this family of enzymes in bacterial survival and 
pathogenicity. 
 The role of non-lipolytic hydrolases (esterases) has been overlooked in 
mycobacterial biology. Studies have revealed their importance in detoxification of 
byproducts and drugs, especially generated during stress environment. For instance, 
propionate accumulation is toxic to mycobacteria; studies have shown that 
mycobacteria have evolved to divert the byproduct propionyl-CoA and methyl-
malonyl-CoA for energy metabolism and lipid synthesis67,180. Certain secretory 
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esterases may play a structural role in modifying envelope composition through its 
esterase activity172,181. Alternatively, it is also possible that they are opportunistic 
energy generators by acting on storage lipids like soluble TAGs, cholesterol esters or 
even on free esters in the local environment like detergents in in vitro culture 
conditions68,182-185. A detailed characterization of non-lipolytic hydrolases is required 
in order to elucidate their role in the survival of mycobacteria.  
 
1.3.6 Inhibitors of lipases and esterases 
 The major hurdle in combating TB is the development of an effective drug 
towards latent stage bacteria. The challenge lies in the identification of suitable 
dormancy-specific metabolic pathways in metabolically sluggish mycobacteria. 
Several studies have reported drugs based on whole cell and target based screening 
with several limitations186. For instance, infiltrating the rigid lipid-rich cell wall, 
functional redundancy of target genes, and most importantly, the metabolic state of 
tubercle bacilli that thrive in different micro-environments inside granulomas, perhaps 
dissimilar metabolic gene expression within the population187. In order to combat TB, 
a multi-target and metabolic stage dependent drug needs to be identified.  
 In section 1.3.4 and 1.3.5, we reviewed the current understanding about 
carboxylester hydrolases (both lipolytic and non-lipolytic enzymes) in mycobacterial 
biology. Carboxylester hydrolases could be an effective drug-targeting candidate 
against latent TB disease. Diverse serine-esterase specific inhibitors are known, such 
as organophosphates188, phosphates189-191, alkyl- or aryl-sulphonates192. However, 
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tetrahydrolipstatin (THL), an FDA approved anti-obesity drug, represents the first 
known selective and irreversible inhibitor for TAG lipases193. 
 
1.3.7 Tetrahydrolipstatin (THL) 
1.3.7.1 Chemistry and mechanism of action 
 Tetrahydrolipstatin (THL) is derived from lipstatin, a natural lipid from 
Streptomyces toxytricini. It was first isolated and the structure was elucidated in 
1978194. Lipstatin is produced by Claisen condensation of two fatty acids, 3-
hydroxytetradeca-5,8-dienoic acid and hexylmalonic acid, followed by the 
esterification of N-formyleucine on a polyketide backbone195-197. Catalytic 
hydrogenation of lipstatin generates THL, a serine-esterase inhibitor. 
 Chemically, THL belongs to the mycolic acid family, which are α-alkyl-β-
hydroxyl long-chain fatty acids displaying 2-alkyl substitution. The mycolic acid 
moiety of the THL contains hydroxyl groups at the 3- and 5- positions; the 3-hydroxy 
group forms a reactive β-lactone ring and that in the 5-position is esterified with an 
amino acid, N-formyl-1-leucine (Figure 1.11)198. The β-lactone ring is a leading 
feature of THL and forms an ester with the serine hydroxyl group of the catalytic triad 
of the lipase199. THL is biologically active and the chemical structure has been worked 
out and proven by chemical synthesis200,201. The mechanism of action of THL is 
demonstrated by a 3D-crystal structure of THL-bound fatty acyl synthase-thioesterase 
domain (FAS-TE). The study showed THL as a competitive inhibitor that works by 
fitting the palmitic core into the hydrophobic substrate-binding pocket and the 
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hexanoyl tail packing against the catalytic histidine, thereby significantly delaying 
hydrolysis202,203. THL, physically, is a white powder, soluble in organic solvents, such 
as heptane, chloroform and DMSO with very long shelf-life at 4 °C. 
 
 
Figure 1.11. Chemical structure of Tetrahydrolipstatin (THL). Chemically, THL 
consists of three structural scaffolds, an N-formyl-L-leucine moiety, a 16-carbon 
palmitic core forming a β-lactam ring and a hexanoyl tail. 
 
1.3.7.2 Anti-obesity and anti-cancer drug 
 Tetrahydrolipstatin is a US Food and Drug Administration (FDA) approved 
anti-obesity drug. The mechanism of action of THL involves inhibition of gastric and 
pancreatic lipases, thereby preventing the breakdown of dietary TAGs into absorbable 
free fatty acids, which are excreted undigested198,199.  
 In addition to its anti-obesity activity, several recent studies have reported that 
the THL is a potent inhibitor of tumor cells. THL acts on the thioesterase domain of 
fatty acyl synthase I (FAS-I), thereby interfering with cellular lipid metabolism and 
induces endoplasmic reticulum stress, causing a halt in cell proliferation leading to 
apoptosis of tumor cells204-207. The potential of THL or its more potent analogues as 
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anti-tumor drugs is very high and further research and validation of their activity is 
required. 
 
1.3.7.3 Anti-mycobacterial drug 
 Given the structural analogy between THL and mycolic acid, and also based on 
its anti-FAS I activity in tumor cells, THL was hypothesized to be an inhibitor of anti-
FAS II or related enzymes. Kremer et al. (2005) showed the primary target of THL is 
FAS II system involved in mycolic acid biosynthesis208. Upon THL treatment they 
reported partial inhibition of mycolic acid biosynthesis by preventing incorporation of 
acetate in mycolates. In addition, they also observed accumulation of TAGs in THL 
treated mycobacteria. In contrast, gene microarray analysis showed up-regulation of 
various lipid-metabolizing genes in THL treated Mtb, especially putative lipase and/or 
esterases (lipD, lipV, A85c, tesB1 and rv1683)209. Later, Cotes et al. (2007) 
demonstrated THL as a potent inhibitor of rv0183 MAG lipase activity124. Rv3802c, a 
mycolic acid biosynthesis gene with phospholipases/thioesterase activity was reported 
to be the THL target in Mtb210. Subsequently, THL was shown to prevent intracellular 
lipolysis during nutrient starvation condition by probably acting on TAG lipases in 
different mycobacterial species123. Recently, a membrane-associated acyltransferase 
(chp1) involved in Mtb sulpholipids-1 biosynthesis was shown to be inhibited by 
THL211. Altogether, several studies have reported carboxylester hydrolases as targets 
for THL, although with poor consensus. 
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1.4 Specific Aims of The Study 
 The lack of drugs that are effective against the latent form of TB is a major 
drawback in the current anti-mycobacterial drug regime, and the development of a 
drug targeting multiple proteins in a physiologically heterogeneous bacilli population 
is a necessity. Studies on NRP mycobacterial biology have illustrated the importance 
of carboxylester hydrolases in mycobacterial survival and pathogenicity. 
 We propose that THL, an FDA approved anti-obesity drug, can be potentially 
used as an effective drug against mycobacteria resuscitating from NRP by acting as an 
inhibitor of mycobacterial carboxyl ester hydrolases. Thus, the objectives of this study 
were to: 
1. Demonstrate sensitivity of resuscitating mycobacterial cultures to THL. 
2. Identify the THL targets in logarithmic growing mycobacterial cells. 
3. Understand the regulation of expression of the identified THL targets during 
the different mycobacterial metabolic states 
4. Validate and define the roles of these THL targets in mycobacterial biology. 
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 Chapter 2 
Materials and methods 
 
2.1 Bacterial Strains and Growth Media 
 Mycobacterium bovis Bacille Calmette-Guérin (BCG) Pasteur strain (ATCC 
35734) and over-expression mutants were grown in Dubos liquid medium 
(supplemented with 10% Dubos medium albumin, and 0.03% Tween 80), or in 
Middlebrook 7H11 agar (supplemented with 10% oleic acid-dextrose- albumin-
catalase enrichment, and 0.5% glycerol) at 37 °C. For pre-cultures, 7H9 broth was 
used containing ADS (0.5 % albumin, 0.2% dextrose/sucrose and 0.08% sodium 
chloride) and 0.05% Tween-80. All media and supplements were purchased from BD 
Difco (Detroit, MI, USA). The antibiotic kanamycin (Sigma-Aldrich, St Louis, MO, 
USA) was added to the culture media at 50 µg/mL concentrations for E. coli and 30 
µg/mL for M. bovis BCG when required. 
 
2.2 Mycobacterial cultures 
 Culturing conditions including logarithmic (or exponentially growing, L), 
hypoxia-induced NRP (N) and regrowth (R) from NRP were adapted from 
standardized protocols84. Inocula used for starting various cultures were prepared from 
single colonies picked from 7H11 agar plates and pre-cultures were propagated in 
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roller bottles rotated at 50 rpm for three days with an initial optical density at 600 nm 
(OD600nm) of 0.05. M. bovis BCG NRP cultures were generated by subjecting bacilli to 
the slow withdrawal of oxygen as described106. Briefly, aerobic cultures (780 mL) with 
an initial OD600nm of 0.005 were expanded in glass bottles with a capacity of 1,000 mL 
(Duran, Wertheim, Germany), achieving an optimal (0.5) headspace ratio (HSR) of air 
volume to liquid volume as specified64,106. The sealed cultures were stirred gently at 80 
rpm for 18 days to allow the bacilli to enter into NRP. Subsequently, fresh oxygenated 
air was re-introduced to hypoxic cultures through loosening of the caps to exit from 
NRP for three days. This exposure of air allowed NRP bacilli to regrow (Figure 2.1). 
Oxygen depletion in these cultures was monitored by the use of the oxygen indicator 
methylene blue as described previously106. Growth and survival were monitored by 
enumeration of CFU on Middlebrook 7H11 agar after plating of appropriate dilutions. 
Plates were sealed with parafilm and incubated at 37 °C for four weeks. 
Figure 2.1. M. bovis BCG hypoxia-induced NRP model. The plot (not drawn to 
scale) illustrates the growth curve of hypoxia-induced NRP culture. The days 
highlighted by red circles are different metabolic states of mycobacteria, as reported 
previously (Figure 1.6). The insert (on left side) shows the experimental set-up. 
Madhu Sudhan Ravindran 67 
2.3 Cloning procedures 
2.3.1 Mycobacterial genomic DNA isolation 
 Mycobacterial cells were grown to OD600nm 0.8 in Dubos medium. Cells were 
harvested by pelleting at 3000 g for 10 min at 4 °C and washed with PBS-T (0.05% of 
Tween-80). Pellet is resuspended in 600 µL of buffer containing 3% SDS, 1 mM 
calcium chloride, 10 mM Tris-HCl, and 100 mM sodium chloride. Cells were 
transferred to screw cap tubes containing 0.1 mm-diameter silica beads (BioSpec 
Products, OK, USA), and were disrupted by using a bead beater at 50 rpm for 5 
minutes at 4°C. The lysate was centrifuged and 2 mM of EDTA was added to the 
supernatant. A mixture of phenol/chloroform/isoamyl alcohol (49:49:2, v/v/v) was 
added to make up the volume to 2X and left for 1 min at room temperature. Upon 
centrifugation at 16,000 g for 5 min the aqueous phase was collected and 0.1 volume 
of 3 M sodium acetate and 0.8 volume of isopropanol were added to precipitate DNA. 
After centrifugation at 16,000 g for 15 min the pellet was collected and washed with 
500 µL of 70% ethanol. The supernatant was removed and the pellets were left to dry 
for 10 minutes at room temperature. The precipitated DNA pellets were resuspended 
in 100 µL of TE buffer and stored at -20 °C until required. 
 
2.3.2 Construction of over-expression plasmids 
 The over-expression plasmids were constructed in partnership with Srinivasa Rao, NITD. 
 Genes involved in lipid metabolism namely, lipN (BCG2991c), lipH 
(BCG1460c), lipV (BCG3229) and tesA (BCG2950) were PCR amplified from 
genomic DNA isolated from M. tuberculosis H37Rv using primers listed in Table 2.1. 
Madhu Sudhan Ravindran 68 
Table 2.1: Primers used for gene amplification and cloning 
 
Gene Probe Sequence (5’—3’)a 
lipN (BCG2991c) forward GCAGATCTATGACCAAGAGTCTGCCAGGT 
reverse GCAAGCTTTCAAACCCGGCTAAGGTGCGC 
lipH (BCG1460c)  forward GCAGATCTATGACAGAGCCGACCGTCGC 
reverse GCAAGCTTTTATGCGTGCAACGCCCTCTT 
tesA (BCG2950) forward GCAGATCTATGCTGGCCCGTCACGGACCA 
reverse GCAAGCTTCTAAGCTCGATCATGCCATTG 
lipV (BCG3229)  forward GCAGATCTTTGCCCGAAATCCCCATCGCC 
reverse GCAAGCTTCTAGCGCGGACCCAGTCGACT 
a Restriction sites are underlined: forward BglII; reverse HindIII  
  
 The PCR fragments were inserted into BglII and HindIII sites of the E. coli- 
Mycobacterium shuttle vector pMV262212 and placed under the control of the 
constitutive HSP60 promoter. 
 
2.3.3 Electroporation and selection of transformants  
 Single colonies of M. bovis BCG were pre-cultured in 7H9 media containing 
ADS (0.5 % albumin, 0.2% dextrose/sucrose and 0.08% sodium chloride) and 0.05% 
Tween 80.  The culture was propagated and grown up to OD600nm 0.8 and harvested by 
centrifuging at 3500 rpm for 10 minutes at room temperature. The pellet was washed 
twice with 50 mL of 0.05% Tween 80 and aliquots were stored in cryotubes at -80 °C 
until further use. 200 µL of BCG competent cells were taken in electroporation 
cuvettes with electrode gap of 2 mm (Biorad lab, USA) and 200 ng of plasmid was 
added and left at room temperature for 10 minutes and electroporated using Biorad 
gene pulser Xcell using the following settings 2500 V, 800 ohm, 25 µF. The 
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tranformants were diluted in 1 mL of 7H9 media, transferred to sterile tubes and left 
over-night at 37 °C. Next day, cells were centrifuged at 3500 rpm for 5 minutes at 4 
°C and pellet was resuspended in fresh 1 mL of 7H9 media and plated on to 7H11 agar 
plates containing 30 mg/mL kanamycin. The plates were sealed and left at 37 °C for 
four weeks. 
 
2.4 Drug inhibitory concentration 
2.4.1 Minimal inhibitory concentration (MIC50) 
 The growth inhibition curve of M. bovis BCG by THL and the alkyne handle 
containing analogue compound was obtained in a 96-well plate assay. THL dilutions 
in the various logarithmic concentrations were prepared in DMSO as indicated and 
added to 200 µL of OD600nm 0.02 culture of BCG at different metabolic states. The 
final DMSO concentration was maintained at 0.5%. The 96-well plates were then 
incubated at 37 °C for 5 days without shaking following which the culture OD600nm 
was recorded. MIC50 was determined by plotting the mean average slope of absorption 
(derived from three independent experiments) versus probe concentration and the 
minimum THL concentration required to inhibit 50% of BCG growth was determined. 
Data was analyzed using GraphPad Prism software (Version 5.0a, GraphPad Software, 
USA). 
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2.4.2 Minimal bactericidal concentration (MBC) 
 The MBC for THL was calculated by plating appropriate dilutions of bacterial 
cultures that were grown for 5 days in the presence of various logarithmic 
concentrations on 7H11 agar plates and the CFU were counted after 3 weeks of 
incubation at 37 °C.  Data was analyzed using GraphPad Prism software (Version 
5.0a, GraphPad Software, USA). 
 
2.5 Protein extraction 
 Cells of M. bovis BCG were harvested by centrifugation at 4,000 g for 20 
minutes at 4 °C, washed thrice with cold PBS-T (0.05% Tween 80). Cell pellets were 
resuspended in PBS and lysed using a probe sonicator at 60% amplitude for 5 minutes 
at 4 °C. The intact bacteria and cell debris were pelleted by centrifugation at 12,000 g 
for 15 minutes at 4 °C.  The supernatant was snap frozen and stored at -80 °C until 
use. 
 For isolation of detergent soluble fraction, the lysed cells were centrifuged at 
2300 g for 5 minutes at 4 °C and supernatant was collected. To 25 µL of supernatant, 
20% Triton X-114 (final concentration of 2%) was added and left at 4 °C for 20 mins 
at 1000 rpm to make a homogenous solution. The insoluble particles were removed by 
centrifuging at 15,700 g for 10 mins at 4 °C. Supernatant was collected in new tube 
and phase separation done at 37 °C for 15 mins at standstill. The detergent soluble 
lower phase was collected into new tube and processed for protein separation on SDS-
polyacrylamide gel electrophoresis. 
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2.6 Chemicals, THL analogues and click reagents 
 Tetrahydrolipstatin (Orlistat), Tris(2-carboxyethyl) phosphine (TCEP) and 
Tris[(1-benzyl-1H-1,2,3-triazol-4-ly)methyl]amine (TBTA) were purchased from 
Sigma-Aldrich, USA. THL-alkyne analogues, rhodamine-azide, biotin-azide were 
synthesized by our collaborator as described previously (Figure 2.2)201. THL and its 
analogues were dissolved in DMSO for all experiments. Avidin coated agarose beads 
slurry (NeutrAvidin) was purchased from Thermo Scientific (MA, USA). FITC-
conjugated ester, CMFDA (5-Chloromethylfluorescein Diacetate) was purchased from 
Invitrogen, USA. 
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Figure 2.2. Chemical structure of azide and alkyne compounds for cycloaddition 
reaction. 
A. THL analogues differ in position of the alkyne handle (shown in dotted circles). 
Chemical structure of B. Rhodamine-azide dye, C. Biotin-azide for enrichment. D. Di-
azo-biotin-azide or dual probe for enrichment as well as visualization. 
The synthesis of chemicals in figure 2.2 is done by Peng-Yu Yang and Shao Q. Yao201. 
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2.7 Huisgen cycloaddition reaction 
2.7.1 Fluorescent tagging 
 M. bovis BCG total protein concentration was adjusted to 1 µg/µL using PBS 
and 100 µg of protein was incubated with 5 µM of THL-alkyne analogues at room 
temperature for an hour. Subsequently, the Huisgen cycloaddition reaction (Figure 
2.3A) was initiated by adding 20 µL of a freshly premixed solution containing 1 mM 
CuSO4, 1 mM TBTA, 100 µM TCEP and 100 µM rhodamine-azide. The reaction was 
stirred at room temperature for 2 hours in the dark and proteins were precipitated by 
the addition of five volumes of ice-cold acetone followed by overnight incubation at -
20 °C. Protein pellets were then washed with methanol and resuspended in 50 µL of 
1x SDS loading dye. Approximately 10 µg of protein was separated on 12% SDS-
polyacrylamide gel, followed by in-gel fluorescence scanning (Figure 2.3B) with 
Typhoon 9410 Variable Mode Imager scanner (GE Amersham, UK) and total protein 
was visualized using coomassie R-250 staining (Biorad, CA, USA). 
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Figure 2.3. Visualization of THL-bound mycobacterial targets by Huisgen based 
azide-alkyne reaction. 
A. Schematic representation of azide-alkyne based Huisgen cycloaddition reaction, 
which involves covalent bond formation between terminal alkyne containing 
compounds with azide bearing reporter molecules. B. Bacterial lysate incubated with 
THL-alk was tagged to rhodamine-azide and the proteins separated on SDS-
polyacrylamide gel are visualized by fluorescent scanning. 
 
2.7.2 Target enrichment 
 For target enrichment, 2 mg of protein was used to perform Huisgen 
cycloaddition reaction and after acetone precipitation, proteins were resuspended in 
0.2% SDS in PBS and sonicated briefly at 14 °C. Solubilized proteins were processed 
for cycloaddition reaction as mentioned above, except that biotin-azide was substituted 
for rhodamine-azide. The supernatant were then incubated with 25 µL of pre-washed 
NeutrAvidin agarose beads. Beads were collected by centrifugation and washed thrice 
with 1 mL of buffer A (8 M urea, 200 mM NaCl, 2% SDS, 100 mM Tris pH 8), buffer 
B (8 M urea, 1.2 M NaCl, 0.2% SDS, 100 mM Tris pH 8, 10% ethanol, 10% 
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isopropanol), buffer C (8 M urea, 100 mM Tris pH 8) and finally with PBS. Proteins 
were eluted from beads by using 25 µL of 2x SDS-loading dye and boiling for 20 
minutes at 96 °C. 20 µL was separated on 12 % SDS-polyacrylamide gel and enriched 
proteins were visualized by silver staining (Figure 2.4)213. 
 Gel lanes corresponding to both DMSO-treated (control) and THL-alk1 treated 
samples were excised using clean surgical blades either as a single bands or whole 
lane and in-gel trypsin digestions were performed as described previously200. The 
eluted peptides were vacuum-dried and stored at -20 °C until analysis. 
 
Figure 2.4. Enrichment of THL-bound mycobacterial targets by Huisgen based 
azide-alkyne reaction. Bacterial lysate incubated with THL-alk was tagged to biotin-
azide and the proteins were captured using avidin-agarose beads. Enriched proteins 




2.8 Western blot 
 12% polyacrylamide gels containing resolved proteins were soaked in transfer 
buffer (0.58% Tris base, 0.3% glycine, 0.0375% SDS and 20% methanol). Proteins 
were transferred to nitrocellulose membrane (Biorad, USA) using Biorad semi-dry 
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transfer cell apparatus for 1 hour at 100 mA. Transfer was confirmed using Ponceau 
staining (Sigma, USA) and the membrane was washed with TBS-T (0.9% Tris base, 
0.12% sodium chloride, 0.05% Tween 20 and pH 7.5) then blocked with 5% fat free 
milk in TBS-T for 30 minutes at room temperature, followed by incubation with 
1:2,500 anti-biotin antibody (Sigma-Aldrich, USA) for 2 hours. After washing thrice 
with TBS-T the membrane was incubated for an hour with 1:10,000 anti-mouse 
secondary antibody (Biorad, USA). After washing with TBS-T, 1:1 mixture of 
Horseradish peroxidase (HRP) and hydrogen peroxide (Thermo, USA) was added and 
membrane was exposed to photographic film (Thermo, USA).  
 
2.9 Proteomics 
2.9.1 Two-dimensional (2D) electrophoresis 
 Samples obtained after Huisgen cycloaddition reaction were cleaned using 2D-
clean-up kit (GE health care, UK) according to the manufacturer’s protocol and at the 
final step the samples were resuspended in rehydration buffer (8 M urea, 2% CHAPS, 
2% pharmalyte, 0.002% bromophenol blue and 35% dithiothreitol). 250 µL of sample 
was spread uniformly on 18 cm strip holder and 2D-gradient strip of pH 4-7 (GE 
health care, UK) was placed on the holder. The strip was overlaid with 2 mL of cover 
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Steps Function Current (V) Time (hrs.) 
Step 1 Step-n-hold 30 V 12 hrs 
Step 2 Step-n-hold 200 V 1 hr 
Step 3 Step-n-hold 500 V 1 hr 
Step 4 Gradient 8000 V 1 hr 
Step 5 Step-n-hold 8000 V 55067 Vhr 
Step 6 Step-n-hold 800 V 10 hrs 
 
 The run was stopped when step 6 reached 800 V. Strips were then equilibrated, 
treated with 1% dithiothreitol (DTT) and 2.5% iodoacetamide (IAA) for 15 minutes at 
room temperature and run on a standard second-dimension 10% SDS-polyacrylamide 
gel electrophoresis as described214. 
 
2.9.2 Peptide MS Analysis  
 Prior to analysis of peptide by mass spectrometry (MS), the dried tryptic-
digested peptides were dissolved in 1% formic acid and peptides were separated and 
analyzed on a UFLC system (Shimadzu, Japan) coupled to an LTQ-FT Ultra (Thermo 
Electron, USA). A 60 minutes gradient was developed using mobile phase A (0.1 % 
formic acid in water) and mobile phase B (0.1 % formic acid in acetonitrile). LTQ-FT-
MS was operated at electrospray potential of 1.5 kV in positive mode at a full m/z 
range of 350-1600. A gas-flow of 2 L/min, ion-transfer tube temperature of 180 °C 
and collision-gas pressure of 0.85 mTorr was used. 
 
2.9.3 Peptide MS data searching and processing 
 Peptide and protein identification was performed using MASCOT search 
engine (version 2.2.07; Matrix Science, US) with an MS tolerance of 10 ppm and 
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MS/MS tolerance of 0.8 Da. Two missed cleavage sites of trypsin were allowed. The 
proteins were identified based on their protein scores greater than 80 (p < 0.05), low 
expectation values, larger sequence coverage, and higher numbers of unique matching 
peptides correspond to confident identifications. Respective accession numbers and 
their functional information were obtained from the National Center for Biotechnology 
Information website (http://www.ncbi.nlm.nih.gov/), BCGList and Tuberculist 
databases (http://genolist.pasteur.fr/). ClustalW (version 2) was used for multiple 
sequence alignment and predictions of transmembrane helices (TMHMM Server 
version 2.0) and signal peptides (SignalP Server version 3.0) were carried out at the 
ExPASy Proteomics server (http://ca.expasy.org/). 
 
2.10 Lipid Extraction 
 50 mg (dry weight) of M. bovis BCG was used for lipid extraction. For 
triacylglycerol (TAG) extraction, cells were resuspended in 3 mL of chloroform-
methanol (2:1, vol/vol) and phase separation done with 1.5 mL of water. The organic 
phase was dried under a stream of nitrogen and stored at -20 °C until further analysis. 
For PDIM and PGL lipid extraction, cells were resuspended in a biphasic mixture of 
methanolic saline (10:1, vol/vol methanol in 0.3% NaCl) and petroleum ether (2:1, 
vol/vol). The upper organic phase was collected and dried under a stream of nitrogen. 
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2.11 Thin layer chromatography (TLC) 
 Dried lipids were resuspended in 100 µL of chloroform/methanol (1:1, vol/vol) 
and 10 µL of the resuspended lipids was spotted on to silica gel 60-coated HPTLC 
plates (20 x 20 cm, Merck, US). For TAG analysis, the plates were developed using 
hexane-diethyl ether-formic acid (45:5:1, vol/vol/vol) as the solvent system and for 
PDIM analysis, plates were developed thrice with petroleum ether-ethyl acetate (98:2, 
vol/vol). For phenolic-glycosylated PDIM, a 2-D TLC analysis was performed using 
chloroform-methanol (96:4, vol/vol) and toluene-acetone (80:20, vol/vol) as 1D and 
2D solvent system. Once dried the plates were sprayed uniformly with 5% 
phosphomolybdic acid in 95% ethanol and heated at 125 °C for 10 minutes to 
visualize total lipids. 
 
2.12 Liquid chromatography and mass spectrometry (LC-MS) of lipids 
 LC-MS analysis of TAG and short-chain esters was performed by 
resuspending the dried lipids in chloroform-methanol (1:1, vol/vol) and 5 µL of the 
resuspended lipid was injected into LC-MS (Thermo scientific, US) connected with 
C18 column with ammonium acetate-acetic acid (98:2, vol/vol) and ammonium 
acetate: water (98:2, vol/vol) as solvent system. The samples eluted from column were 
injected in LTQ-FT (Thermo scientific, US) operated at positive mode with 
electrospray potential at 1.5 kV and m/z range of 200-1500. 
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2.13 Enzymatic assay and IC50 
 The activity of recombinant lipH expressed in M. bovis BCG was measured by 
using p-nitrophenyl (pNP) esters (Sigma Aldrich, USA) with butyrate chain (C4). The 
release of pNP was monitored at 400 nm by using a 96-well plate spectrophotometer 
(Figure 2.5) and quantified by using a calibration curve of pNP-C4. Enzymatic 
reactions were performed with 2.5 mM Tris buffer (pH 8.0) containing 300 mM Nacl 
with 1 mM sodium tauro-deoxycholate (NaTDC) at room temperature over a period of 
15 min in a final volume of 250 µL containing various amounts of enzyme and 1 mM 
substrate. Results are expressed as specific activities in international units/mg, 
corresponding to 1 µmol pNP released per minute and per mg of enzyme. 
 
Figure 2.5.  Measurement of esterase activity using para-nitrophenyl (p-NP) 
esters as substrates. Mycobacterial lysates were incubated with p-nitrophenyl-esters 
and the formation of p-nitrophenyl was measured spectrophotometrically at 400 nm. 
 
 For enzymatic IC50, various log concentration of THL was pre-incubated with 
culture lysate before preforming enzymatic bio-chemical reaction. IC50 was 
determined by plotting the mean average slope of absorption (derived from three 
independent experiments) versus probe concentration and the concentration of 50% 
inhibition of reaction was determined. 
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2.14 RNA isolation and quantitative RT-PCR 
 Mycobacterial culture pellets were washed with PBS and mixed with two 
volumes of cell lysis buffer (Qiagen, USA). The cell lysate was then transferred to 
screw cap tubes containing 0.1 mm-diameter silica beads (BioSpec Products, US). 
Cells were disrupted for 5 minutes at 50 revolutions using a bead beater at 4 °C, and 
unlysed bacteria and cell debris were pelleted by centrifugation. The supernatants were 
used to isolate total RNA with RNeasy mini kit (Qiagen, USA) according to the 
manufacturer’s protocol. DNase-treated RNA samples (1 µg) were reverse transcribed 
using 50 ng random hexamer and SuperScript III RT-PCR kit (Invitrogen, USA) 
following the manufacturer’s instructions. Quantitative PCR reactions were carried out 
using Taqman RT-PCR master mix kit (Applied Biosystems, USA) containing 30 ng 
of cDNA template, 250 nM primers and 125 nM probe (Table 2.2) with standard 
conditions as recommended by the manufacturer. No-reverse transcriptase and no-
template controls were included as negative controls. Relative quantification was 
performed using comparative threshold cycle (CT) method. Data was analyzed using 
Graph Pad prism (version 5; USA). 
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Table 2.2. RT-PCR primers for lipH, tesA, lipN, lipV and sigA 
 
 
2.15 Fluorescent labeling of LDs and quantification of esterase activity 
 For lipid droplet staining, M. bovis BCG cells were washed with PBS-T 
(0.05% Tween 80) and incubated with 50 ng/mL of LD540215 (a lipophilic dye based 
on the Bodipy fluorophore) for 15 minutes at room temperature. For esterase activity, 
washed cells were incubated with 1 µM of 5-Chloromethylfluorescein Diacetate 
(CMFDA) (Invitrogen, USA) at 37 °C for 15 minutes. Stained cells were washed with 
PBS and fixed with 4% paraformaldehyde for 15 minutes. Fixed cells were processed 
further for microscopy or flow cytometry analysis. 
 
2.16 Flow cytometry 
 The clumps from the fixed cells were removed by passing through polyamide 
60 µM mesh fabric (Sefar, Germany). Data was acquired using a BD LSR Fortessa 
cell analyzer (BD Biosciences, US) equipped with an air-cooled 15 mW, 500 nm 
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argon laser. The flow rate was adjusted to 100-200 events per second. Flow cytometry 
data were analyzed using the FlowJo software, version 8.8.7 (TreeStar, USA). 
 
2.17 In silico characterization of lipH 
 BLAST searches with the current databases were performed at the National 
Center for Biotechnology Information website (http://www.ncbi.nlm.nih.gov/). 
ClustalW (version 2) was used for multiple sequence alignment and predictions of 
transmembrane helices (TMHMM Server version 2.0) and signal peptides (SignalP 
Server version 3.0) were carried out at the ExPASy Proteomics server 
(http://ca.expasy.org/). The NeoGlyc program was used to predict potential 
glycosylation sites, and MeMo was used to predict potential arginine or lysine sites for 
methylation. A homology model of the three-dimensional (3D) structure of lipH was 
generated using SWISS-MODEL server (http://swissmodel.expasy.org/). The protein 
sequence was submitted against the non-redundant sequence database for structural 
classification of proteins and the Protein Data Bank (PDB). Molecular graphics 
software program Swiss PDB Viewer was used to display and draw the structure from 
the PDB files generated by the SWISS-MODEL and validated using Structural 
Analysis and Verification Server (http://nihserver.mbi.ucla.edu/SAVES/). Docking 
was performed using Autodock (http://autodock.scripps.edu/), which uses a genetic 
algorithm to dock flexible ligands into flexible active site of protein. The ligand 3D 
structures were constructed with BUILDER module of molecular modeling program 
Accelrys Insight-II. The active site was then analyzed using the CASTp program and 
molecular overlay was done using Accelrys Discovery Studio. 
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2.18 Statistical Analysis 
 Data obtained from at least three independent experiments were combined 
together for statistical analysis. Results were analyzed using GraphPad Prism software, 
Version 5.0a (GraphPad Software, USA). Statistical significance was tested using 
Student’s t test, p < 0.05 was considered to be significant. 
Madhu Sudhan Ravindran 85 
Chapter 3 
THL binds α /β-hydrolase family proteins 
3.1 Introduction 
 The importance of lipids in the life cycle of Mtb has been well established and 
reported to play important role in bacterial survival, virulence and pathogenicity81,117. 
However, the enzymes involved in mycobacterial lipid metabolism have been poorly 
studied and weakly correlated to its life cycle. The decade-old Mtb genomic data has 
revealed the presence of 250 lipid metabolizing enzymes, underlining the contribution 
of these genes in bacterial survival and/or pathogenicity5,69. Based on comparative 
sequence analysis, 94 gene products were identified as members of the α/β-fold 
carboxyl hydrolase superfamily, including the ‘Lip family’ of 24 lipases/esterases 
(lipC to Z, except K and S)168,171. Carboxylester hydrolases are an important class of 
enzymes performing multiple functions ranging from lipid metabolism, cell wall 
maintenance, virulence, etc. Among these annotated lipase/esterase genes, only two 
have been structurally and functionally characterized to date. 
 Therefore, to better understand the contribution of lipases and esterases in 
mycobacterial biology, we employed a chemical proteomic tool called activity-based 
protein profiling (ABPP) (Figure 3.1). Several studies have previously used ABPP to 
identify drug targets. The method basically involves the use of a terminal alkyne-
containing compound that can be covalently tagged to azide bearing reporter molecule. 
The tagging is based on the principle of the Huisgen cycloaddition reaction31,201,216. 
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 Tetrahydrolipstatin, a well-characterized serine esterase inhibitor, was 
previously shown to inhibit both the active and NRP form of mycobacteria by acting 
on lipid metabolic enzymes. However, its protein target and mechanism of action is 
still controversial, with different groups claiming different proteins as THL 
targets124,208-211. To better understand its biological activity by identifying THL targets, 
we used the chemical-biology (ABPP) approach. To begin, we selected THL-
analogues bearing alkyne handles from ligand library201,217 and screened these 
analogues for bacteriostatic activity and ABPP based protein profiling, to show that 
the THL-alk1 analogue is the best candidate with a biological activity similar to THL. 
Hence, we used a cycloaddition reaction to capture, enrich and identify THL-alk1 
binding proteins using biotin-avidin-based enrichment. Proteins identified as THL-
alk1 targets show that the drug is specific towards lipase characteristic α/β-hydrolases, 
which include lipases, esterases, transferases, peptidases and dehalogenases. The 
proteins with high-confidence score were tentatively assigned to the fluorescent band 
on SDS-PAGE. Collectively, in this study a chemical biology approach was developed 
to identify and validate THL targets in mycobacteria. 
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Figure 3.1. Schematic representation of the steps involved in azide-alkyne based 
Huisgen cycloaddition reaction. The 6-step reaction involves incubation of THL-
analogues with mycobacterial lysates, followed by tagging for visualization or 
enrichment via the Huisgen cycloaddition reaction. The tagged proteins are separated 
on SDS-polyacrylamide gel and identity of the protein was validated by peptide 
sequencing. 
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3.2 Results 
3.2.1 Efficiency of THL-alkyne analogues in M. bovis BCG 
To evaluate the anti-mycobacterial activity of THL, we determined the 
bacteriostatic activity by defining the minimal inhibitory concentration of the drug 
required to inhibit 50% of bacterial growth (MIC50). M. bovis BCG grown in Dubos 
base broth containing 0.05% Tween 80 was incubated with various logarithmic 
concentrations of THL and OD600nm was recorded after 5 days. THL showed an MIC50 
in the range of 21±1 µM (Figure 3.2). 
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Figure 3.2. Anti-mycobacterial activity of THL. The bacteriostatic activity of THL 
is evaluated by incubating various log concentration of drug with mycobacterial 
cultures and the MIC50 is defined as the concentration that inhibits bacterial growth by 
50%. Error bars when not displayed are smaller than the markers (open circles). 
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Previous reports on anti-lipase activity of THL prompted us to check the total 
TAG levels in mycobacteria treated with THL66. We incubated logarithmic phase 
mycobacterial cells with 80 µM THL for 4 days and the total TAG level was analyzed 
using LC-MS (Figure 3.3A) and high-performance thin-layer chromatography 
(HPTLC) (Figure 3.3B). We observed a nearly 2 to 4 fold increase in TAG level upon 
80 µM THL treatment compared to DMSO control cells. This data is in line with 
previous reports where THL has been shown to be TAG lipase inhibitor66.  
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Figure 3.3. TAG utilization is reduced in THL treated M. bovis BCG. 
A. LC-MS profile of lipid extracts from logarithmic BCG culture incubated for 4 days 
with 40 µM THL and DMSO control. The peaks were further characterized by MS/MS 
analysis. Note: the peak at m/z 700.62 was also observed in solvent blank run. B. 
HPTLC run of lipid extracts from logarithmic BCG culture incubated for 4 days with 
80 µM THL and DMSO control. The values represent fold change in TAG level 
compared to DMSO control. The MS analysis in fig 3.3A is done in partnership with Amaury 
Cazenave Gassiot, NUS. 
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 To gain further knowledge into the mechanism by which THL could act as a 
bacteriostatic and/or bactericidal agent, we performed ABPP using THL as bait to 
search for proteins that were targeted by THL. We selected three THL-alkyne 
analogues (THL-alk1, -alk2 and -alk3) (Figure 2.2) from a previously synthesized 
THL-alkyne probe library201,217. The analogues were selected based on the position of 
the alkyne handle in different structural scaffolds of the THL chemical structure as 
shown in Figure 1.11. We then screened the analogues for bacteriostatic activity 
(MIC50), which showed analogue THL-alk1 has an MIC50 value of ~20 µM. This 
value was close to the value obtained with THL (21±1 µM) compared to the other two 
analogues (Figure 3.4A). 
 To check the efficiency of analogues binding to their target, we performed 
Huisgen cycloaddition reaction with all three analogues to screen for proteins that 
were targeted by THL. THL-analogues were incubated with M. bovis BCG cell lysate, 
followed by cycloaddition reaction with rhodamine-azide. The reactions were 
separated on SDS-polyacrylamide gel, and rhodamine labeled protein was detected by 
in-gel fluorescence scanning. THL-alk1 showed significantly more fluorescent protein 
bands compared to the other two analogues (Figure 3.4B). The specificity of the 
reaction was further confirmed through a competition reaction, by pre-incubating 25 
µM THL with cell lysate followed by the Huisgen cycloaddition reaction with 5 µM 
THL-alk1. The presence of THL caused a decrease in the amounts of proteins binding 
to THL-alk1 as observed by in-gel fluorescence (Figure 3.4C). Based on the above 
findings, where THL-alk1 showed better bacteriostatic activity and efficient binding to 
its targets, compared to the other two analogues, we selected THL-alk1 for further 
studies.
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Figure 3.4. Efficiency of THL analogues in M. bovis BCG. 
A. MIC50 study of THL-alkyne analogues with logarithmic phase BCG culture. B. 
Mycobacterial cell lysates incubated with THL-alkyne analogues (probe 1, 2 and 3) 
are tagged to rhodamine-azide. Labeled proteins are separated on SDS-polyacrylamide 
gel and visualized by in-gel fluorescence scan followed by coomassie staining (gel on 
the left side). The lanes are labeled as molecular weight marker (Mw), DMSO control 
(—) and THL-alk reaction (+). C. Mycobacterial cell lysate was pre-incubated with 25 
µM THL, followed by incubation with 5 µM THL-alk1 analogues. Incubated proteins 
are tagged with rhodamine-azide using Huisgen cycloaddition reaction. Labeled 
proteins are separated on SDS-polyacrylamide gel and visualized by in-gel 
fluorescence scanning. Lane 1: reaction with THL-alk1, and lane 2: reaction pre-
incubated with THL (orlistat) followed by incubation with THL-alk1. 
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3.2.2 THL targets α/β-hydrolase family proteins in M. bovis BCG 
 To identify the THL-alk1-bound proteins in Figure 3.5A, we performed a 2D-
gel electrophoresis with the intention of identifying individual proteins based on their 
isoelectric point. The 2D-gel electrophoresis would have been followed by peptide 
sequencing. However, the fluorescent scan of 2D gel revealed that seven bands were 
in the form of streaks and we were unable to distinguish distinct spots (Annex 6), 
probably due to interference of click-reagents during IEF and/or saturation of 
rhodamine-azide labeled proteins. Therefore, we changed our strategy to perform 
biotin-avidin based target enrichment. 
 Lysates from logarithmic M. bovis BCG, were incubated with THL-alk1 or 
control (DMSO) and tagged to biotin-azide via Huisgen cycloaddition reaction. 
Targeted enrichment of THL-alk1-bound proteins was performed using avidin-coated 
agarose beads. Proteins eluted from beads were separated on SDS-polyacrylamide gel. 
Silver staining of these gels showed significant enrichment of THL-bound proteins 
(Figure 3.5B), whereas control sample had no distinguishable protein signal, save for 
those coming from avidin, which was also eluted from the beads. The protein 
enrichment was further validated using fluorescent biotin-azide and anti-biotin 
antibody (Figure 3.5 C and D). 
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Figure 3.5. Visualization and enrichment of THL-alk1-bound proteins in BCG. 
A. Mycobacterial proteins incubated with THL-alk1 and DMSO control were tagged 
to rhodamine-azide dye by Huisgen cycloaddition reaction. Equal amounts of proteins 
were separated on SDS-polyacrylamide gel and visualized by in-gel fluorescence 
scanning, followed by coomassie staining (gel image on left side). B. THL-alk1-bound 
targets were enriched using cycloaddition reaction based biotin-avidin pull down. 
Enriched products were separated on SDS-polyacrylamide gel and silver stained. The 
bands indicated on the right side were excised and subjected to LC-MS/MS analysis. 
C. Mycobacterial proteins incubated with THL-alk1 and DMSO control were tagged 
to a diazo-biotin-azide. Equal amounts of proteins were separated on SDS-
polyacrylamide gel and visualized by in-gel fluorescence scanning, followed by silver 
staining (gel image on left side). D. Mycobacterial proteins incubated with THL-alk1 
and DMSO control were tagged to biotin-azide and western blot was used to detect 
biotin-bound proteins. In all figures, the lanes are labelled as molecular weight marker 
(Mw), DMSO control (—) and THL-alk1 reaction (+). 
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 Silver stained protein bands between 25-55 kD from both DMSO control and 
THL-alk1 lanes were excised corresponding to fluorescent gel shown in Figure 3.5A 
and subjected to tryptic digestion. Peptides were identified using LC-MS/MS. Data 
sets were filtered from DMSO control sample and proteins with >80 ion scores with 2 
or more peptide matches and corresponding molecular weight are summarized in 
Annex 1A. Notably, 60% (15 proteins) of the top 25 hits belong to α/β-hydrolase 
family proteins (Figure 3.6A), which includes a variety of enzymes catalyzing myriad 
reactions, such as esterases, lipases, epoxide hydrolases, dehalogenases, proteases and 
peroxidase, (Figure 3.6B). Proteins with a high ion score for the specific silver stained 
band and respective molecular weight were assigned to fluorescent bands based on 
their molecular weight. Of these, BCG2241c, lipD, lipM, lipN, Ag85c, lipI, lipH, 
lipW, BCG3408, BCG1252 and tesA are reviewed in Table 3.1. 
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Figure 3.6. THL targets α/β-hydrolase family proteins. 
A. THL targets identified in mycobacterial logarithmic phase lysate were filtered from 
the DMSO control sample and 25 top-hit protein scores are classified into enzyme 
families based on their reported function and sequence similarity search. B. Sub-
classification of 15 hydrolases (all belongs to α/β-hydrolase family protein). 
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Table 3.1. THL targets in BCG total cell extracts derived from logarithmically growing culture a 
 
a Data obtained from 3 independent experiments was filtered from DMSO control and 
targets consistent in all experiments were selected based on their protein scores, queries 
matched, and molecular weight 
b Accession number and protein name in Tuberculist and BCGList database 
c,d Protein functions and localization are based on details annotated in Tuberculist database 
and also based on protein sequence homology search 
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Chapter 4 
 Hyper-resistivity of esterase enhanced mycobacteria to THL 
when resuscitated from non-replicative state 
4.1 Introduction 
 The reason why Mtb is one of the most potent pathogens is its ability to persist 
in the host for extended periods of time without causing disease. Mycobacteria can 
reactivate at a later stage when the host immune response is compromised42,218,219. 
During the latency stage, the tubercle bacilli are quarantined in a structure called 
granuloma, and it is believed that the conditions inside the granuloma, such as 
hypoxia, low pH, nutrient starvation, etc., drive the bacilli into a dormant state. These 
dormant, non-replicating bacilli are thought to possess altered metabolism, which 
induces the latent stage of the disease65,87,112. Numerous studies have addressed the 
role of intracellular TAG accumulation and utilization in latent mycobacteria as an 
energy source, however, the metabolic processes and enzymes necessary for the 
tubercle bacilli to harness TAGs as an energy source in order to transit to and from this 
NRP state are not well characterized48,63,66. We therefore seek to obtain a functional 
insight into the expression and regulation of lipases and esterases in different 
mycobacterial metabolic states by extending the ABPP study on mycobacterial 
logarithmic state to NRP and regrowth culture (refer chapter 3). This enabled us to 
identify and then track the carboxylester hydrolases in different metabolic states of 
mycobacterial NRP. 
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 Studies on in vitro culture models that generate quiescent organisms by oxygen 
deprivation (hypoxia) have shown that mycobacteria store fatty acids (FAs) in the 
form of TAG enriched LDs62,83,105. During resuscitation via the re-introduction of 
ambient oxygenated air under sterile conditions, these LDs are utilized as carbon 
source. Our group has previously shown that THL prevents the breakdown of TAG to 
fatty acids that are utilized as energy source when these hypoxic bacilli are 
resuscitated66. We used hypoxia-induced NRP cells to examine the effect of THL on 
different metabolic states and demonstrated that THL is more effective against 
mycobacteria resuscitating from NRP compared to actively growing mycobacteria. We 
also show that the total cellular esterase/lipase level is up-regulated during regrowth 
from NRP, and THL targets these families of enzymes, thereby preventing bacterial 
regrowth. Intriguingly, our experiments reveal that the down-regulation of these 
enzymes does not occur at the transcriptional level, but rather at or after post-
translation level. 
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4.2  Results 
4.2.1 Total cellular esterase activity is diminished during NRP and revived 
during regrowth 
 To examine the metabolic activity of mycobacteria in different culture states, 
we used the Wayne model to generate hypoxia-induced NRP and regrowth (in 
presence of air) cultures. We chose specific time points based on the established 
metabolic states of the bacilli, namely, day 0 (logarithmic), day 4 (NRP-1), day 9 
(early NRP-2), day 14 (mid NRP-2), day 18 (NRP) and day 19, 20, 21 (regrowth 
phases). The growth curves, OD600nm and CFU at these time points were plotted. The 
curve showed no increase in growth of mycobacteria during hypoxic-NRP between 
days 4 to day 18, whereas once oxygen (air) was provided at day 18 the culture growth 
resumed (Figure 4.1A and B). Subsequently, we also checked the total cellular TAG 
levels to further confirm the metabolic state of mycobacteria. The TAG levels were 
either analyzed by lipid extraction followed by TLC (Figure 4.1C) or flow cytometry 
of TAG specific-LD540 stained cells (Figure 4.2A). The analysis showed that 
mycobacteria accumulates TAG during NRP and utilizes it during regrowth. 
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Figure 4.1. Hypoxia-induced NRP model in M. bovis BCG.  
A. Growth profile of BCG Wayne model recorded at OD600nm. After day 18, the 
regrowth of the NRP bacilli was induced by providing fresh air. B. CFU was counted 
by plating cultures on 7H11 agar plates. The data are represented as the mean values ± 
standard deviation (n=3). C. HPTLC analysis of TAG levels in hypoxia-induced NRP 
and regrowth BCG cultures. TAG: Triolein standard. Error bars when not displayed 
are smaller than the marker (filled circles). 
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 To correlate the TAG lipid kinetics with carboxylesterase kinetics, we assessed 
the total LD and cellular esterase level by staining mycobacteria at logarithmic (day 
0), NRP (day 18) and regrowth (day 21) stages. As demonstrated previously, 
mycobacteria accumulate and utilize LDs during entry and exit from NRP, 
respectively. Therefore, we used neutral lipid dye (LD540) to stain LDs. Flow 
cytometry analysis of stained cells confirmed LD buildup and consumption 
accordingly (Figure 4.2A). At the same time, to examine the cellular esterase activity 
we stained cells with ester-linked fluorescent dye (CMFDA) (for details refer section 
2.13) and flow cytometry analysis showed a reverse trend for CMFDA as compared to 
LD540 staining (Figure 4.2B). 
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Figure 4.2. Mycobacterial cellular carboxylesterases follow a reverse trend as 
compared to LD build-up and break-down. 
A. LD kinetics in mycobacteria in logarithmic (L), NRP (N) and regrowth (R) cells 
stained with LD540 dye. B. Flow cytometry analysis of total cellular esterase activity 
measured by hydrolysis of FITC tagged ester (CMFDA). Dot plot represents log 
intensity against percentage (%) count. The value within grid represents percentage 
(%) events. The data were analyzed using One-way ANOVA and are represented as 
the mean values ± SEM (n=3). * p < 0.05, ** p < 0.01, *** p < 0.001. 
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4.2.2 THL is effective against mycobacteria resuscitating from NRP 
 To examine the effect of THL on M. bovis BCG in different metabolic states, 
we determined the MIC50 value of THL towards mycobacteria at logarithmic (day 0), 
regrowing from NRP (day 18) and regrown (day 21) cultures. Various concentrations 
of THL were incubated with the cultures and we observed a significant (p < 0.01) 
change in drug sensitivity of mycobacteria regrowing from NRP (14±2 µM), 
compared to logarithmic (21±1 µM) and regrown cells (19±3 µM) (Figure 4.3A). The 
MIC50 value clearly indicates the sensitivity of regrowing cells towards THL, 
compared to cells regrown from NRP-2. In contrast, ethambutol (EMB), a first line 
anti-tuberculosis drug, did not show significant differences in MIC50 value for 
resuscitating cells (Annex 5).  
 We also determined the MBC of THL by determining the CFU of BCG 
incubated for 5 days with different concentrations of THL. We observed that the 
colony-forming potential of regrowing bacilli was severely impaired (p < 0.05) 
between 10 and 31 µM THL, indicating that mycobacteria regrowing from NRP 
cultures were more sensitive to THL. No substantial differences were seen for the 
MBC between logarithmic and regrown mycobacteria (Figure 4.3B). Collectively, 
these results demonstrate that proteins targeted by THL are essential for mycobacterial 
resuscitation from NRP. 
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Figure 4.3. THL is effective against mycobacteria resuscitating from NRP. 
A. MIC50 studies of THL at different metabolic states, logarithmic growing, regrowing 
from NRP and regrown from NRP, were performed by incubating mycobacterial 
cultures with different THL concentrations at 37 °C for 5 days. Culture density was 
recorded at OD600nm and MIC50 was determined as the concentration of THL that 
inhibits bacterial growth by 50%. The MIC50 from four independent experiments were 
analyzed using One-way ANOVA and are represented as the mean values ± SEM 
(n=3). * p < 0.05, ** p < 0.01.  B. MBC was calculated by plating cultures incubated 
for 5 days with various concentrations of THL. The CFU were counted and plotted 
against THL concentration. The data were analyzed using One-way ANOVA and are 
represented as the mean values ± SEM (n=3). * p < 0.05.  
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4.2.3 THL targets are regulated in biphasic pattern in different metabolic states  
 To determine the THL target in mycobacterial NRP and regrowth, we 
performed ABPP with THL-alk1. After cycloaddition reaction the proteins were 
separated on SDS-polyacrylamide gel and scanned for in-gel fluorescence. 
Interestingly, we observed the fluorescence intensity of certain proteins weakened as 
the bacteria entered into NRP from the logarithmic stage and the intensity revived 
during resuscitation from dormancy (Figure 4.4A). This suggested that the proteins 
bound to THL showed a biphasic pattern of their expression depending upon the 
metabolic state of the bacteria. Notably, bands labeled as 3, 4, 5 and 6 showed this 
pattern of expression; such that the fluorescence intensity levels were down-regulated 
during NRP and up-regulated during regrowth. In contrast the intensity of bands 
labeled as 1, 2 and 7 remained constant throughout the different metabolic states. 
Next, using Huisgen cycloaddition reaction based THL target enrichment (Figure 
4.4B) we identified and compared the THL-targets at various mycobacterial metabolic 
states.  
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Figure 4.4. THL targets are regulated in a biphasic pattern in different metabolic 
states. 
A. Mycobacterial cell lysates from various metabolic states (logarithmic, NRP and 
regrowth) were incubated with THL-alk1 and DMSO control. Huisgen cycloaddition 
reactions were performed using rhodamine-azide dye. Equal amounts of proteins were 
separated on SDS-polyacrylamide gel and visualized by in-gel fluorescence scanning, 
followed by coomassie staining (gel image on left side). The lanes are labeled as 
molecular weight marker (Mw), DMSO control (—) and THL-alk1 reaction (+). The 
fluorescent bands indicated from 1-7 on the right side were further characterized by 
target enrichment followed by LC-MS/MS analysis. B. THL-alk1-bound targets in 
mycobacterial NRP and regrowth lysates were enriched using Huisgen cycloaddition 
reaction based biotin-avidin pull down. Enriched products were separated on SDS-
polyacrylamide gel and silver stained. Protein bands in the range of 25-55 kD were 
excised and subjected to tandem MS analysis. Note that the protein streak between 27-
35 kD and around 15 kD is possibly avidin polymers eluted from beads. The lanes are 
labeled as molecular weight marker (Mw), DMSO control (—) and THL-alk1 reaction 
(+). 
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 The sequencing data obtained from a pull-down enrichment gel were filtered 
from the DMSO control sample and proteins with >80 ion scores and 2 or more 
peptide matches are summarized in Annex 1, 2 and 3. In total, we identified 247, 27 
and 74 proteins in logarithmic, NRP and regrowth phases respectively. By segregating 
the top 25 proteins from each phase into enzyme families, we observed that the 
hydrolase family showed a biphasic pattern from 60% at logarithmic to 32% in NRP 
and revived back (52%) during regrowth phase (Figure 4.5A). Interestingly all 
identified proteins in the hydrolase family belonged to α/β-fold hydrolase superfamily. 
We noted that the top hit protein in the NRP phase, BCG2654, was absent in the 
logarithmic phase and further information from BCGlist and sequence search revealed 
that BCG2654 is a dosR regulon hypothetical protein with a protease domain and α/β-
hydrolases structural feature (Figure 4.5B). Altogether, the above data suggest that 
THL targets the α/β-hydrolase proteins in the logarithmic state, and our data also 
suggest that most of these proteins are down regulated during NRP and retrieved back 
during regrowth. 































Figure 4.5. Proteins targeted by THL in logarithmic state are down-regulated 
during NRP and revived during regrowth. 
A. High confidence top 25 THL targets at logarithmic (L), NRP (N) and regrowth (R) 
states, are grouped based on their protein family and plotted in percentage. Please 
refer to page 111 for fig 4.5B. 
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Figure. 4.5. Proteins targeted by THL in logarithmic state are down-regulated 
during NRP and revived during regrowth. 
B. THL α/β-hydrolases targets in logarithmic (L), NRP (N) and regrowth (R) phases. 
Black and white box represents presence and absence of the indicated proteins from 
specific metabolic states in THL target list. 
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4.2.4 Regulation of α/β-hydrolases occurs at protein level 
 In the previous section, we showed that certain lipase/esterase proteins follow a 
biphasic pattern in NRP stages. To check whether these proteins are regulated at 
transcriptional level, we performed qRT-PCR on lipN (BCG2291c), lipH (BCG1460c), 
tesA (BCG2928) and lipV (BCG3229). The genes were chosen on the basis of their 
intensity in the fluorescence gel (Figure 4.4A). Whereas lipH was diminished during 
NRP, tesA and lipN remained constant throughout NRP. lipV was chosen as a negative 
control as no fluorescence was observed around its molecular weight range of 23.7 
kDa. Interestingly, none of these proteins showed significant change in mRNA profile 
(Figure 4.6), suggesting that these proteins are regulated post-transcriptionally or 
post-translationally possibly through changes in their degradation rate. This 
observation indicates that α/β-hydrolase expression is down-regulated during NRP 
and up-regulated during resuscitation, which is also evident from total cellular esterase 
activity (Figure 4.2C). 
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Figure 4.6. Quantitative real time-PCR analysis of lipN, lipH, tesA and lipV at 
different metabolic stages. Total RNA was isolated from cells at different metabolic 
states and used for qRT-PCR analysis of lipN, lipH, tesA and lipV. The ΔCT values 
against endogenous control (sigA) was normalized against ΔCT value of logarithmic 
culture (day 0) and thus obtained ΔΔCT value is plotted. The bars indicate means, and 
the error bars indicate standard deviations (n=3). 
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 The data obtained from protein, mRNA and cellular enzymatic profiles 
prompted us to check for regulation of proteins identified in THL targets at different 
bacterial fractions. One way of regulating lipid-catabolizing proteins is translocation 
of the proteins from cytosol to membrane, which serves as a rapid and energy-efficient 
way to store and retrieve proteins under metabolic stress like hypoxia, starvation, etc. 
76,220-222. In order to access the membrane-localized proteins, the THL-incubated BCG 
lysates from different metabolic states were phase-separated into detergent soluble and 
insoluble fractions and subjected to Huisgen based cycloaddition reaction to examine 
the change in protein intensity in insoluble versus soluble fraction. No significant 
change in insoluble fraction proteins was observed at different mycobacterial 
metabolic states (Figure 4.7A), suggesting that other protein regulation mechanisms 
like post-translational modification or protein degradation could possibly play a role.  
In addition, we also checked whether THL targets missing in the soluble fraction are 
enriched in lipid droplets. These neutral lipid structures are known to be enriched in 
NRP cells (Figure 4.7B) and a possible location to store and retrieve proteins during. 
However, ABPP showed no significant THL target enrichment (Figure 4.7C and D). 




Figure 4.7. α/β-hydrolases are not regulated by stress-dependent translocation of 
proteins to insoluble fractions. 
A. Mycobacterial proteins incubated with THL-alk1 were phase separated into Triton 
X-114 soluble and insoluble fractions and tagged to fluorescent-azide dye by Huisgen 
cycloaddition reaction. Equal amount of proteins were separated on SDS-
polyacrylamide gel and visualized by in-gel fluorescence scanning, followed by 
coomassie staining (left gel image). The lanes are labeled as molecular weight marker 
(Mw), logarithmic (L), NRP (N) and regrowth (R). Proteins bands marked on right 
side represent proteins identified by LC-MS/MS. B. HPTLC run of TAG extracted 
from LDs. C. Mycobacterial LDs isolated from NRP cells were incubated with THL-
alk1 (+) and DMSO (—) control was tagged to rhodamine-azide dye. Sample was 
delipidated and equal amounts of protein were separated on SDS-polyacrylamide gel 
and visualized by in-gel fluorescence scanning. D. THL-alk1-bound LD proteins were 
enriched using biotin-avidin pull down. Enriched products were separated on SDS-
polyacrylamide gel and silver stained. 
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Chapter 5 
The short-chain esterase activity of lipH is inhibited by THL 
 
5.1 Introduction 
 Genomic microarray and proteomic screening studies have been used to 
determine gene and protein expression patterns in tubercle bacilli in response to 
different environmental conditions83,84,177,223-225. However, poor correlation between 
expression and functional patterns has hindered the complete understanding of 
different lipases and esterases in mycobacterial metabolic states. In addition, 
mutational studies of lipases and esterases have not completely elucidated their 
physiological role because of their functional redundancy and involvement in different 
metabolic states48,226. 
 To better understand the THL activity and contribution of lipases and esterases 
in mycobacterial hypoxia-induced NRP, we over-expressed four of the identified THL 
targets (lipN, lipH, lipV and tesA) in BCG. We show that over-expression of THL 
targets leads to increased resistance of mycobacteria towards THL. In addition, lipH 
over-expression causes aggregation of cells during regrowth from NRP and lipid 
profile showed diminished utilization of TAGs during regrowth. Finally, using in vitro 
enzymatic assay, we show that lipH is a short-chain esterase and its catalytic activity 
is inhibited in presence of THL. 
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5.2  Results 
5.2.1 Over-expression of tesA and lipH leads to increased bacterial resistance to 
THL 
 Our data suggest that THL inhibits mycobacterial resuscitation by targeting 
members of the α/β-hydrolase family proteins such as BCG2241c, lipD, lipM, lipN, 
Ag85c, lipI, lipH, lipW, BCG3408, BCG1252 and tesA. To further validate the 
identified targets and their functional properties, we over-expressed lipN 
(pBCG2291c), lipH (pBCG1460c), tesA (pBCG2928) and lipV (pBCG3229) genes. As 
stated in section 4.2.4, the genes were chosen on the basis of their intensity in ABPP 
gel, with lipH being down-regulated during NRP in contrast to tesA and lipN that 
remain constant throughout NRP. LipV was chosen as a control. The genes were 
cloned into the E. coli-Mycobacteria shuttle vector pMV262 under the control of 
hsp60 promoter, constitutively expressed mycobacterial heat shock protein (hsp). To 
simplify the nomenclature, we will simply use the term ‘lipH strain’ for example, to 
represent ‘M. bovis BCGpMV262-lipH over-expression strain’. 
 Over-expression of the genes was verified by the increase in mRNA expression 
by qRT-PCR with sigA as internal normalization standard (Figure 5.1A). The mRNA 
level of lipN, lipH, tesA and lipV increased by 5-, 10-, 50- and 5- fold respectively, and 
the increase in mRNA levels was reflected at the protein level by approximately 80- 
and 60-fold increase in lipH and tesA protein intensity as determined by ABPP 
(Figure 5.1B). No significant increase in protein intensity was observed in the case of 
lipN and lipV over-expression. The over-expression of lipH and tesA was additionally 
confirmed by analyzing the total cellular esterase activity using flow cytometry based 
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ester-linked fluorescent dye (CMFDA). The assay showed significant change in total 
cellular esterase activity compared to wild type (WT) mycobacteria (Figure 5.1C). 
Based on this, we chose lipH and tesA for further studies. 
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Figure 5.1. Over-expression of α/β-hydrolases validates lipH and tesA as THL 
targets. 
A. qRT-PCR mRNA profile of lipN, lipH, tesA and lipV over-expression in 
comparison to WT. The ΔCT values against endogenous control (sigA) was normalized 
against the ΔCT value of WT mRNA and thus obtained ΔΔCT value was plotted. The 
bars indicate means, and the error bars indicate standard deviations (n=3). B. Huisgen 
cycloaddition reaction with THL-alk1 and DMSO (control) incubated mycobacterial 
lysates from WT and over-expression strains. Equal amounts of protein were separated 
on SDS-polyacrylamide gel and visualized by in-gel fluorescence scanning, followed 
by Coomassie staining (gel image on left side). The lanes are labeled as molecular 
weight marker (Mw), DMSO control (—) and THL-alk1 reaction (+). The lipH and 
tesA molecular weight regions are marked on right. C. Flow cytometry analysis of 
total cellular esterase activity measured by hydrolysis of FITC-tagged ester (CMFDA). 
Histogram represents log intensity against percentage (%) count. 
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 To examine whether over-expression of lipH and tesA had any effect on the 
susceptibility of the bacteria towards THL, we determined the MIC50 of THL for over-
expression strains. Indeed, we observed that mycobacteria over-expressing lipH 
(pBCG1460c) and tesA (pBCG2928) required higher doses of THL for inhibition. 
MIC50 values showed that over-expression of lipH (33±5 µM) and tesA (32±3 µM) in 
BCG caused an increase of almost 50% in bacterial resistance to THL compared to the 
vector control (pMV262) and parental BCG strain (WT) (Figure 5.2A). In addition, 
BCG transformed with non-THL targets genes (rv1109 and rv1428) did not show 
significant change in MIC50 value compared to WT strain (data not shown). 
Furthermore, the MBC data also confirmed the resistance of the over-expressing 
strains towards THL (Figure 5.2B). The CFU of the over-expression strain was 
significantly more than the parental strain in the presence of the same concentration of 
the drug, indicating that over-expression of lipH or tesA decreased the susceptibility of 
the bacteria to THL. Altogether, our experiments confirmed that lipH and tesA are 
specific targets of THL and suggests that these genes play a crucial role in 
mycobacterial metabolism during NRP. 
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Figure 5.2. Over-expression of lipH and tesA leads to increase in resistance to 
THL. 
A. MIC50 study for THL against BCG over-expression strains was performed by 
incubating mycobacterial cultures with different THL log concentration at 37 °C for 5 
days. Culture density was recorded at OD600nm and MIC50 were determined as the 
concentration of THL that inhibits bacterial growth by 50 %. B. MBC was calculated 
by plating cultures incubated for 5 days with various concentration of THL and 
bacterial colonies were counted and plotted against THL concentrations. The data 
were analyzed using One-way ANOVA and are represented as the mean values ± SEM 
(n=3). * p < 0.05, ** p < 0.01. nd: value not determined. 
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5.2.2 LipH over-expression causes reduced utilization of TAG during regrowth 
 Our data with the over-expression strains suggested that lipH and tesA are 
critically involved in mycobacterial growth kinetics and that blocking the activity of 
these proteins can influence the resistance of the bacteria to THL. To investigate the 
physiological role of lipH during NRP and regrowth phases, cultures of WT, 
pBCG1460c (lipH) and pBCG2928 (tesA) were grown in the hypoxia-induced NRP 
model, before reactivation with air. The growth curves, OD600nm and CFU at various 
time points were compared to WT (Figure 5.3 A and B). The OD600nm plot of over-
expressing strain was similar to the WT strain during NRP stages, whereas CFU 
differed by a log during NRP-2. But the most significant observation was drop in 
OD600nm in lipH strain, compared to WT and tesA strain. We observed severe 
clumping in the lipH over-expressing strain suggesting that the decrease in absorbance 
(OD600nm) could be a result of the clumping rather than growth defect or cell death. 
Moreover, the CFU plot showed normal bacterial regrowth. 
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Figure 5.3. Hypoxia-induced growth curve of BCG over-expression strains. 
A. Growth profile of BCG Wayne model recorded at OD600nm. After day18, the 
regrowth of the NRP bacilli was inducted by providing fresh air. B. CFU for various 
time points (days) were obtained from cultures plated on 7H11 agar plates and 
incubated at 37 °C for four weeks. The data are represented as the mean values ± 
standard deviation (n=3). Error bars when not displayed are smaller than the marker 
(filled circles). 
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 We profiled total cellular TAG levels, which are the potential carbon source 
for regrowing mycobacteria. LC-MS analysis showed no significant change in TAG 
levels in logarithmic and NRP phase for WT, and the tesA and lipH over-expression 
strains (Figure 5.4A and B). In contrast, LC-MS analysis of TAG levels in lipH strain 
indicated that TAG was four times poorly utilized during regrowth compared to WT 
(Figure 5.4C). We confirmed the above findings by measuring total cellular TAG by 
TLC and also analyzed the cells by flow cytometry for lipid droplet staining with 
LD540 (Figure 5.4D and E). Such reduced consumption of TAG in the lipH over-
expression strain could result from either poor reactivation of bacilli from NRP or an 
alternative source of carbon instead of TAG. Since CFU plots of reactivation showed 
normal growth of reactivating bacilli it is likely that lipH substrate provides an 
alternative carbon source for the reactivating cells, thereby bypassing the need to 
utilize the accumulated TAGs. Altogether, the above findings indicate the significance 
of lipH in bacterial resurgence from hypoxia-induced NRP and also indicate the 
presence of other esters as carbon source during bacterial reactivation. 
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Figure 5.4. LipH over-expression causes reduced utilization of TAG during 
regrowth. 
TAGs LC-MS profile of BCG WT and lipH at different metabolic states (A: 
logarithmic, B: NRP and C: regrowth). Individual TAG species are further 
characterized using MS/MS analysis. MS spectra are normalized using internal 
standard d5-TAG m/z 829.8. D. HPTLC analysis of TAG levels in BCG WT and lipH 
over-expression culture at different days of regrowth (R 19, 20, 21) compared to NRP 
(N 18) state. Fold changes in TAG levels compared to D18 are indicated. E. LD 
kinetics at different days of regrowth (R 19, 20, 21) compared to NRP (N 18) state 
represented as percentage of LD540 stained cells as analyzed using flow cytometry. 
The bars indicate means, and the error bars indicate standard deviations (n=3). * p < 
0.05, ** p < 0.01, ns: not significant.  
The MS analysis in fig 5.4 A, B and C is done in partnership with Amaury Cazenave Gassiot, NUS. 
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5.2.3 Short-chain esterase activity of lipH is inhibited by THL  
 Previously in Figure 5.1B and 5.2, we identified lipH as one of the THL 
targets.  In order to show a direct inhibition of lipH activity by THL, we performed an 
in vitro biochemical assay to determine the inhibitory concentration of THL towards 
lipH. Based on the previous biochemical studies, lipH was revealed to have a 
preference towards short-chain p-nitrophenyl esters (C2- C8) 171. Thus, we used a 
chromogenic pNP-C4 as a substrate and tracked the product formation 
spectrophotometrically at various incubation times. The absorption at 400 nm was 
recorded for a reaction containing the substrate (pNP-C4) incubated with different 
mycobacterial whole cell lysates. The product formation in lipH over-expression was 
significantly higher compared to WT and pMV (empty vector) control (Figure 5.5A), 
thereby confirming the lipH esterase activity. In addition, THL at a concentration of 
0.12±0.035 µM was able to inhibit 50% of lipH activity. In contrast, WT had no 
significant IC50 curve, thereby confirming THL as an inhibitor of lipH (Figure 5.5B). 
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Figure 5.5. THL inhibits the catalytic activity of lipH. 
A. In vitro biochemical assay of mycobacterial whole cell lysate with pNP-C4 esters 
shows the increase in product formation in lipH over-expressing strain, compared to 
WT and pMV controls. B. IC50 study for THL was performed, by incubating cell 
lysates (WT and lipH) with different THL logarithmic concentration for various time 
periods. Product formation using substrate pNP-C4 was recorded at 400 nm and IC50 
was determined as the concentration of THL that inhibits enzymatic activity by 50%. 
The data were represented as the mean values ± SD (n=3). Error bars when not 
displayed are smaller than the marker. 
 
The IC50 is done in partnership with Ankit Shukla, for his Master’s dissertation thesis, 2012. 
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 In Figure 4.4A, we showed that lipH levels diminished during mycobacterial 
(WT) hypoxia-induced NRP. In the case of lipH over-expression, where the lipH gene 
was placed under the control of a constitutively expressing promoter (hsp60), we 
observed substantial lipH repression during NRP compared to logarithmic phase and 
revival of lipH expression within a day of regrowth in presence of air (Figure 5.6A). 
This suggested that constitutively expressed lipH is regulated at the protein level. To 
check the activity of lipH under these metabolic states, we repeated the IC50 
experiment with lipH strain at logarithmic, NRP and regrowth lysates and observed 
IC50 values of 0.12±0.035 µM and 0.03±0.007 µM for logarithmic and regrowth 
respectively, whereas NRP state had no significant IC50 curve (Figure 5.6B). The IC50 
value illustrates the absence of lipH to catalyze pNP-C4 in NRP stage. Collectively, 
these studies demonstrate that THL is an inhibitor of short-chain esterases lipH 
(BCG1460c) and also indicate the regulation of lipH during NRP and regrowth. 
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Figure 5.6. Constitutively over-expressed lipH activity is down-regulated during 
hypoxic-NRP. 
A. Huisgen cycloaddition reaction with lipH over-expression strain at different 
metabolic states. After click reaction, equal amounts of protein were separated on 
SDS-polyacrylamide gel and visualized by in-gel fluorescence scanning. Arrow on 
right side represents lipH. Lanes are marked as logarithmic (Day 0), NRP (day 18) and 
regrowth (day 19-21) respectively. B, C & D. IC50 study for THL towards lipH over-
expressing strain at different metabolic states was performed, by incubating cell 
lysates with different THL logarithmic concentration. Product formation using 
substrate pNP-C4 was recorded at 400 nm and IC50 were determined as the 
concentration of THL that inhibits enzymatic activity by 50 %. The data were 
represented as the mean values ± SD (n=3). Error bars when not displayed are smaller 
than the marker. 
 
Figure 5.6 B, C & D IC50 is done in partnership with Ankit Shukla, for his Master’s dissertation thesis, 
2012. 
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5.2.4 In silico-based prediction of ligand specificity of lipH 
 To further understand the interaction of lipH towards its ligands, we performed 
a computational prediction of ligand specificity of the lipH catalytic triad. We first 
generated a 3D protein model of lipH (BCG1460c) based on protein homology using 
SWISS-MODEL software. The top-ranked amino-acid sequence homology hits in 
Protein Data Bank (PDB) for lipH included thermophilic carboxylesterases belonging 
to HSL family from Bacillus acidocaldarius Est2 (44%), Alicyclobacillus 
acidocaldarius G84s (43%), Atchaeoglobus fulgidus AFEST (41%). The model 
revealed that lipH is a globular protein similar to other α/β-hydrolases and consists of 
11 α-helices and a central β-sheet core containing seven parallel β-strands, and an 
anti-parallel β2-strand. The GXSXG sequence motif, characteristic of 
esterases/lipases, was conserved in lipH, with an active serine (Ser162) residue between 
β5 and α5, whereas the invariant motif of HSL family HGG is located 70 amino acid 
upstream of the active serine. The catalytic triad is composed of nucleophilic serine, 
charge relay network aspartate and proton carrier histidine at Ser162, Asp260, His290 
respectively (Figure 5.7 A and B). 
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Figure 5.7. Three-dimensional (3D) model of lipH. 
A. Topology diagram of lipH representing β-sheet and α-helix. The active serine is 
represented by star and two other catalytic amino acids by arrow. The HSL 
characteristic HGG motif is labeled after β7. B. 3D model of lipH structure depicting 
the core α/β-hydrolase fold with catalytic triad (yellow). Note the topology diagram is 
not drawn to scale and its orientation is different from 3D image. 
 
Figure 5.7B. Modeling is done in partnership with Ankit Shukla, for his Master’s dissertation thesis, 
2012. 
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 A previous biochemical kinetic study has shown that lipH efficiently 
hydrolyzes short-chain TAGs and vinyl esters 142,171. We performed a computational 
docking analysis to predict the binding affinity/energy, confirmation and distance of 
ligands from the active site of lipH. The ligand 3D structures were constructed with 
BUILDER module of molecular modeling program Insight-II, assigning standard 
geometric parameters. The atomic charges were assigned to ligands using Amber 
potential and these ligands were then subjected to force field until the r. m. s. energy 
gradient became less than 0.005 Kcal/mol/Å. All hydrogen atoms were then added to 
the 3D protein model and Amber all-atom charges were assigned to the whole protein. 
The active site was analyzed using the CASTp program to recognize and characterize 
accessible surface pockets in the protein based on the solvent accessible surface and 
the molecular surface parameters. 
 Docking was performed using Autodock, which uses a genetic algorithm to 
dock flexible ligands into the flexible active site of a protein. Protein-ligand flexible 
docking was evaluated based on the type of specific interaction (both covalent and 
non-covalent) and inter-atomic distance of ligand with protein active site. The ligand 
binding affinity within the lipH-binding pocket showed binding energy of -7.1 and -
5.1 Kcal/mol and the distance to the active site was observed at 1.82 Å and 2.5 Å for 
THL and vinyl-caproate respectively (Figure 5.8A and B). We also assessed the 
docking of other inhibitors like E600 and PMSF, and lipid substrates such as TAG and 
phospholipids. The binding energy for all these ligands was less than -4 kcal/mol and 
distance more than 3 Å (data not shown). Overall, the in silico prediction 
demonstrated that THL is a superior inhibitor compared to other reported esterase 
inhibitors.




Figure 5.8. In silico approach to characterize the substrate specificity of lipH.  
The lipH 3D model is docked with (A) THL (red) and (B) probable substrate (blue). 
The insert (right side) depicts the catalytic triad and other amino acids interacting with 
docked ligand. 
 
This work is done in partnership with Ankit Shukla, for his Master’s dissertation thesis, 2012. 
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Chapter 6 
Conclusion and Perspective 
6.1 Summary and key findings 
 M. tuberculosis is able to enter a non-replicative state after an initial infection 
when the host mounts an immune response. The tubercle bacillus reactivates when the 
host immune defenses are compromised42,218,219. During latency the pathogen resides 
within the granulomatous lesion in a nutrient deprived, hypoxic environment with 
minimal metabolic activity. Such stress environments within these lesions can 
potentially act as stimuli for the bacilli to change their metabolic states83,87,105. In such 
a state, the drug-resistant and dormant mycobacteria are known to accumulate neutral 
lipids in the form of lipid droplets that are broken down as carbon source during 
regrowth62,66. The lipid catabolism is performed by combined action of carboxylester 
hydrolases like lipases and esterases48,123. To date, only a few lipid-catabolizing 
enzymes have been functionally characterized and shown to be related to 
mycobacterial NRP64,65,174,178. The role of other hydrolases cannot be ruled out, as 
numerous microarray studies have shown that several other lipases and esterases are 
up-regulated under different mycobacterial stress conditions (http://www.tbdb.org/). 
Therefore, to obtain a functional insight into the expression and regulation of lipases 
and esterases in mycobacterial NRP, we attempted a novel chemical-proteomic 
approach using a lipase-ligand as a bait to identify and then track the carboxylester 
hydrolases in different metabolic state of mycobacterial NRP. 
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 Tetrahydrolipstatin, a well-characterized serine esterase inhibitor, was 
previously shown to prevent utilization of TAG during mycobacteria regrowth66. In 
the current study, we used THL as bait to identify its targets in mycobacterial 
logarithmic culture. The targets were identified as lipase characteristic α/β-hydrolase 
fold containing enzymes. We then cultured mycobacteria under different metabolic 
states, and the comparison of identified THL targets showed a biphasic pattern of 
carboxylester hydrolase protein regulation. To prove that such regulation of proteins 
might support bacterial acclimatization to the metabolic states, we expressed and 
partially characterized lipase H (lipH, BCG1460c), a short-chain esterase, to show that 
its product could be an opportunistic carbon source to mycobacteria regrowing from 
NRP. 
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6.2 THL binds α /β-hydrolase family proteins 
 Mtb, unlike other bacteria, encodes numerous carboxylester hydrolases, such as 
lipases and esterases. Recent efforts to understand the functional and mechanistic role 
of this protein family were unsuccessful due to their low expression level, gene 
redundancy and hydrophobicity. In this study, we used a chemical-biology tool based 
on the principle of the Huisgen cycloaddition reaction, which was used by several 
groups for chemical synthesis, molecular tagging, as well as drug target 
identification201,227,228. The basic principle behind the Huisgen reaction is a 1,3-dipolar 
cycloaddition between an azide and an alkyne groups to give a 1,2,3-triazole ring. To 
implement this, we used an antimycobacterial lipase inhibitor, tetrahydrolipstatin as 
bait by selecting THL-analogues (THL-alk1, -alk2 and -alk3) bearing alkyne handle at 
different positions from a ligand library201,217. Three analogues were selected on the 
basis of three scaffolds in the THL chemical structure: an N-formyl-L-leucine moiety 
(or peptidyl moiety), a 16-carbon palmitic core forming a β-lactam ring, and a 
hexanoyl tail. The analogues were screened for their bacteriostatic activity (MIC50) 
(Figure 3.4A), and THL-alk1 showed an MIC50 value close to THL. We then 
performed a Huisgen cycloaddition reaction using the three THL-alkyne analogues 
with rhodamine-azide. The fluorescent scan of SDS-polyacrylamide gel showed that 
THL-alk1 binds more targets compared to other two analogues (Figure 3.4B).  Based 
on these studies, THL-alk1 was selected as the best candidate with a biological 
efficiency similar to THL. The better efficiency of THL-alk1 that has alkyne handle on 
hexanoyl tail holds true with the earlier published 2.3 Å resolution crystal structure of 
human fatty-acyl synthase-thioesterase domain (FAS-TE) in complex with THL. 
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Pemble, et al. showed that the C16 core of THL (orlistat) is reminiscent of palmitate 
and binds almost exclusively to a hydrophobic surface channel, and the N-formyl 
leucine group of THL binds to the interface cavity202. The hexanoyl tail interacts with 
amino acid in short-chain pocket of the FAS-TE, but it is comparatively more exposed 
than the other two THL structural scaffolds. These observations provide a clear 
mechanism for THL action and selectivity towards its enzyme targets. 
 The Huisgen cycloaddition reaction of THL-alk1 in mycobacterial cell lysates 
showed seven prominent fluorescent proteins bands in SDS-polyacrylamide gel 
(Figure 3.5A). In order to identify the proteins present in these bands, we performed 
biotin-avidin based THL target enrichment. The target enrichment was implemented 
due to the low expression level of carboxylester hydrolases in mycobacteria and also 
to remove non-THL target proteins. The target enrichment reaction contains biotin-
azide in place of rhodamine-azide and, once enriched, the proteins were separated on 
SDS-polyacrylamide gel. The protein bands corresponding to seven fluorescent bands 
were excised and identified using peptide-LC-MS/MS. We then processed the data by 
filtering though DMSO control and considering >80 protein scores with two or more 
peptide matches. The targets were assigned to specific bands based on their molecular 
weight, protein score and peptide match, as summarized in Table 3.1. 
 In order to check for low intensity proteins, we also excised the whole lane 
between 25-55 kD and performed peptide LC-MS/MS. After filtering the data though 
DMSO control and considering >80 protein scores with two or more peptide matches, 
we obtained a list of 247 mycobacterial proteins as probable THL targets (Annex 1A). 
In this list, we looked for lipase characteristic α/β-fold hydrolases, which includes 
lipases, esterases, transferases, peptidases, dehalogenases, etc. In total, 29 out of 247 
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proteins were members of the α/β-hydrolase fold family, but by narrowing the list by 
considering only the top 25 proteins, there were 15 α/β-hydrolase (or 60%), of which 
10 were probable lipases and/or esterases (Figure 3.6). This indicates the drug 
specificity towards lipase characteristic α/β-hydrolase family proteins. 
 Although we obtained the proteome of THL-binding carboxylester hydrolases, 
we still cannot rule out the role of other off-target lipases and esterases. For instance, 
we failed to identify mycobacterial starvation up-regulated gene lipY (rv3097c), a 
well-characterized TAG lipase. However, this may be because lipY is not expressed 
under normal (logarithmic) growth conditions and is mainly induced and expressed 
under reactivation during nutrient-limiting conditions229. The target list is in-line with 
previously reported microarray analysis showing that THL treatment induced up-
regulation of putative lipases/esterases (lipD, lipV, A85c, tesB1 and rv1683)209. In 
addition, the list also includes previously reported phospholipases/thioesterase 
rv3802c and MAG lipases rv0183 that are inhibited by THL in in vitro enzyme assay. 
Collectively, in this study we have devised a chemical biology approach to identify 
THL targets in the mycobacterial logarithmic state and we have shown that THL is 
specific towards α/β-fold hydrolase enzymes. The current THL target only includes 
proteins identified in logarithmic phase of mycobacterial culture, considering THL is 
more effective in bacilli resuscitating from NRP, therefore, this technique will be 
further extended to identify THL targets in various metabolic state of mycobacteria. 
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6.3  Esterase enhanced resuscitating mycobacteria is sensitive 
towards THL 
 The selectivity of THL towards the multi-functional hydrolase family that has 
important roles in mycobacterial regrowth from NRP tempted us to check the 
expression of these proteins during the different metabolic states of mycobacteria. In 
view of this, oxygen limitation was used as a means to induce tubercle bacilli into a 
state of NRP and the cells could then be resuscitated from NRP by providing fresh air. 
This method mimics the dormant and reactivation stages of tubercle bacilli during its 
persistence in lung granulomas87. We confirmed the growth phases of the Wayne 
model by observing the OD600nm, CFU and total cellular TAG levels at different stages 
of NRP and regrowth (Figure 4.1). Subsequently, we observed the efficiency of THL 
towards NRP bacteria by performing MIC50 and MBC. The MIC50 of THL towards 
NRP cells (14±2 µM) was 30% less compared to logarithmic culture (21±1 µM) and 
MBC study also showed a significant effect of THL on NRP culture (Figure 4.3). 
Overall, this indicates that THL is an effective drug towards mycobacteria regrowing 
from NRP compared to logarithmic cells (Figure 6.1). This is consistent with a 
previous study66, where THL was shown to prevent TAG utilization in mycobacteria 
resuscitating from NRP. The reason for THL being more effective against regrowing 
cells could probably be due to the higher cellular lipase and/or esterase activity, as 
observed in Figure 4.2. Thereby, during mycobacterial regrowth from NRP certain 
lipolytic enzymes (such as carboxylester hydrolases) are up-regulated, which are 
probable THL targets. 
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Figure 6.1. THL is an effective drug against mycobacteria reviving from NRP. 
 
 Carboxylester hydrolases are an important class of enzymes performing 
multiple functions including lipid metabolism, cell wall maintenance and 
virulence.156,169. Based on comparative sequence and structural analysis of the Mtb 
genome, 94 gene products were revealed as members of the α/β-hydrolase fold 
superfamily, including the ‘Lip family’ of 24 carboxylester hydrolases (lipC to Z, 
except K and S). Among these annotated lipase/esterase genes, only lipY 
(rv3097c)65,229 and lipid-droplet associated BCG1721 (rv1683)64 are experimentally 
proven to have TAG lipase activity. Several microarray-based studies have reported 
up-regulation of certain α/β-hydrolases in mycobacterial survival under different 
metabolic stress conditions (hypoxia, low pH and nutrient starvation). For instance, 
lipC, lipU, lipT, lipX and caeA (rv2224c) were found to be up-regulated among other 
genes in nutrient starvation condition104. Similarly, lipF, lipR and lipX were found to 
be up-regulated under conditions of acid-shock177,178. These studies further highlight 
the importance of carboxylester hydrolases in bacterial survival and pathogenicity. 
Several gene knockout experiments on lipases and esterases have provided sufficient 
evidence on the role of carboxylester hydrolases, but have not ruled out the role of 
other lipases and/or esterases. The presence of nearly 150 lipid-catabolizing genes in 
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Mtb genome indicates that there is a specific expression and regulation of these 
enzymes in addition, to functional and substrate redundancy.  
 In order to identify proteins up-regulated during regrowth that are targeted by 
THL, we deployed ABPP using THL-alk1 as bait. After cycloaddition reaction with 
rhodamine-azide, proteins were separated on SDS-polyacrylamide gel and 
fluorescence scan showed a biphasic protein pattern (Figure 4.4A). Among the seven 
prominent bands identified in logarithmic phase, four of the fluorescent bands were 
observed to diminish as mycobacteria underwent NRP and revived back during 
regrowth. This was further confirmed when we segregated the top 25 proteins 
identified using ABPP in log, NRP and regrowth phases into enzyme families (Figure 
4.5). The plot suggests that hydrolases unlike other enzyme families show the biphasic 
pattern of expression during NRP and regrowth. Interestingly, all the enzymes grouped 
in the hydrolase family belong to the α/β-hydrolases fold class of proteins, which 
includes lipases, esterases, epoxide hydrolases and proteases. Among the α/β-
hydrolases, lipD, lipI, lipH, lipW, BCG3408 and BCG1252 are absent in the NRP 
phase THL target list (Figure 4.5B), but present in logarithmic and regrowth phases. 
The other interesting observation was that the highest protein score in NRP THL target 
list was not expressed in the logarithmic phase. This protein annotated as BCG2654 is 
a dosR regulon hypothetical protein, which is only expressed during NRP. Sequence 
based search revealed that BCG2654 belongs to α/β-hydrolase fold family with a 
protease domain. Overall, the above data indicates that among the α/β-hydrolases 
targeted by THL during logarithmic phase, most of them are down regulated during 
NRP and retrieved back during regrowth.  
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 The potential way of protein regulation during dormancy could be at 
transcriptional, translational or post-translational level. We first checked the probable 
transcriptional regulation by performing qRT-PCR to profile the mRNA level at 
different stages of NRP. We selected lipN, lipH, tesA and lipV on the basis of their 
protein profile in fluorescent gels. Our qRT-PCR data showed that there is no 
significant change in the mRNA level at different stages of NRP compared to the 
logarithmic (day 0) stage (Figure 4.6). This is in line with the previous reports and 
microarray data that did not show changes in the mRNA levels of these genes 83,223. 
We then checked the possibility of protein regulation by post-translational 
modification (PTM). Previous studies have suggested that signal sequence, 
phosphorylation, pupylation, etc., can cause protein translocation into specific 
compartments or can lead to degradation54,76,220-222. We analyzed soluble and insoluble 
fractions of mycobacterial lysate using ABPP. We did not find sufficient evidence of 
protein translocation from soluble to the insoluble cell lysate fraction during NRP 
(Figure 4.7A). Since dormant cells are known to accumulate LDs, we also checked 
the enrichment of THL targets in LDs as a possible compartment to translocate and 
store proteins, so that they can be easily retrieved during regrowth. ABPP showed 
certain bands in the LD fractions (Figure 4.7C and D) and it will be interesting to 
identify and explore the biology of these proteins in the mycobacterial life cycle. 
Previous studies have shown that certain lipases are present in LD, for example, lipid 
droplet associated dual functional BCG1721 was shown to posses TAG lipase 
activity64. Lipase Y (lipY, rv3097c), a membrane associated TAG lipase is reported to 
be up-regulated during starvation65. Another possibility of protein translocation is 
secretion out of the cell. Various mycobacterial secretory proteins are known, but none 
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has been shown to be metabolic state-dependent. We did identify certain genes such as 
lipM, A85c, hypothetical proteases, etc., containing transmembrane domains and/or 
secretion sequences. An in silico study of lipH sequence showed a weak secretory and 
a strong cleavage signal at the N-terminal end of the protein with several 
phosphorylation sites. As HSL in adipocytes are known to be translocated and/or 
secreted by phosphorylation or other similar post-translation modification, it will be 
interesting to identify such stress-dependent protein modification and translocation 
mechanisms in mycobacteria. Future experiments will also explore the Huisgen 
cycloaddition reaction of mycobacterial culture filtrate at different metabolic states. 
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6.4  A short chain esterase, lipH is an opportunistic carbon supplier 
for resuscitating BCG 
 Drug target validation by a protein over-expression strategy is based on the 
concept that elevated levels of the drug target protein confer resistance because higher 
concentrations of a specific inhibitor are required to bind to the excess target in order 
to inhibit bacterial growth. In order to confirm the THL targets and their identity, we 
cloned and expressed some of the identified proteins. THL targets were chosen on the 
basis of their in-gel fluorescence intensity. LipH intensity changed with NRP, whereas 
lipN and tesA intensity remained constant, with lipV chosen as a negative control. 
Over-expression of genes were determined using qRT-PCR and showed that tesA and 
lipH are over-expressed more that 10-fold, and the Huisgen cycloaddition reaction 
with over-expressing strain showed that the protein intensity of lipH and tesA 
increased by 80- and 60-fold, respectively (Figure 5.1). No changes in lipN and lipV 
intensity suggest poor protein expression. An MIC50 and MBC study of lipH and tesA 
over-expression strain showed a ~50% increase in bacterial resistance towards THL 
compared to WT (Figure 5.2). This data further suggests that lipH and tesA are THL 
targets.  
 We checked the growth curve of the over-expressing strains in hypoxia-
induced NRP. No significant changes were observed in OD600nm and CFU reading 
throughout NRP, whereas during regrowth lipH OD600nm decreased dramatically, while 
CFU was same as WT or tesA over-expression strain (Figure 5.3). Although CFU 
reading confirmed normal cell growth, a careful observation of lipH over-expression 
culture showed that during regrowth there was severe cell clumping in lipH over-
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expression strains, a probable reason for poor OD600nm reading. We speculated that the 
clumping of the lipH over-expressing strain could be due to degradation of the Tween 
80 detergent, which is a culture media supplement added to prevent cell clumping. The 
possible reason for Tween 80 degradation could be due to action of lipH secreted from 
the over-expression cells. Previous studies have shown that certain mycobacterial 
carboxylester hydrolases (like esterase and cutinase) can act on culture media Tween 
80184,185,230, and utilize as a probable carbon source for bacterial growth.  
 Cannan et al. have shown in vitro lipH substrate preference towards short-
chain esters171, and, in Figure 5.5, we reproduced the assay using the same 
chromogenic substrates to demonstrate increase in the esterase activity of 
mycobacteria by several fold due to lipH over-expression. In addition, we also used 
the assay to depict that the esterase activity is inhibited by THL with an IC50 of 
0.12±0.035 µM. We then checked the constitutively over-expressed lipH levels in 
mycobacteria under different metabolic states using the Huisgen cycloaddition 
reaction. To our surprise, we observed diminished lipH protein levels in over-
expression strain at NRP state, compared to logarithmic state and the levels were 
revived within a day of regrowth. An IC50 study showed similar pattern, confirming 
that the regulation of lipH occurs at protein level and the rapid kinetics of its 
expression indicate the tight regulatory mechanisms of bacteria and underscore the 
importance of the lipH to reactivate growth.  
 Several groups have hypothesized the role of mycobacterial esterases (non-
lipolytic hydrolases) in lipid metabolism, energy metabolism and detoxification 
processes. Presumably, lipH might play the role of a detoxifying enzyme during 
mycobacterial growth and also during stress conditions (like hypoxic-NRP). For 
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example, when mycobacteria switch their energy source to lipids during NRP, the 
generated byproducts such as toxic propionate are then converted to esters such as 
coenzyme A and are probably metabolized or diverted to other pathways by 
esterases67,68. Studies have also reported stress-based post-translational modification 
and protein translocation. Such modifications are possible with lipH, which can cause 
lipH secretion into extracellular region or lipid droplets, where lipH might feed on 
extracellular esters to provide additional carbon source. We performed in silico 
analysis and observed that lipH has signal sequence and cleavage sequence at the N-
terminus of the amino acid sequence. In addition, lipH possess several 
phosphorylation and other potential PTM sites. Extracellular esterase activities are 
previously reported to prevail in other mycobacterial carboxylester hydrolases230. For 
example, rv2224c (caeA) is an α/β-hydrolase with preference for free substrate in the 
local environment and can cause modification in the membrane composition172. LipC 
is reported to be secretory and immunogenic with a preference for extracellular short-
chain esterase174 and rv0183 is an exported MAG inhibited by THL124. In addition, 
three of the seven Mtb cutinase-like proteins are reported to be present in culture 
filtrate or membrane fraction with preference towards phospholipids and/or esters 
125,175,210,230. In recent report, mouse macrophage HSL was shown to be up-regulated 
upon M. leprae infection231, and, from sequence based homology searching we found 
that the macrophage HSL top sequence homology in mycobacteria is lipI and lipH, 
with 34% identity. Considering all the above evidence, we propose that the 
mycobacterial genome encodes enzymes like lipases and esterases that have specific 
expression profiles depending on the physiological state of the bacteria, and that under 
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stress conditions the expression, localization and substrate preference of these 
enzymes might change. 
 
 
Figure 6.2. Mycobacterial TAG versus carboxylester hydrolases kinetics at 
different metabolic states. Values obtained from TAG-TLC (Figure 4.1C), gel band 
intensity (Figure 4.4A) and total cellular esterase activity (Figure 4.2B) was 
normalized and plotted in percentage for three mycobacterial metabolic stages: 
Logarithmic (L), NRP (N) and regrowth (R). 
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6.5  Future perspective 
 Future studies to understand the role of α/β-hydrolases in mycobacterial 
biology should include following objectives: 
 
6.5.1 Identification of THL targets in NRP bacilli membrane and culture 
filtrate fractions 
 One of the promising future directions would be to screen for THL targets in 
mycobacterial fractions, such as membrane and culture filtrates. In current study, we 
have shown that in soluble cell lysates certain THL targets are diminished during NRP 
and proposed that they might be translocated into other mycobacterial fractions. By 
performing ABPP with THL incubated membrane or culture filtrate, might help to 
further understand the mechanism and identify the factors facilitating bacterial 
survival under NRP.  
 Several studies have reported the importance of secretory lipases or esterases 
in mycobacterial survival and pathogenicity. To date, two mycobacterial lipases 
rv2224c (caeA) and rv0183 and a short-chain esterase are characterized, as secretory 
carboxylester hydrolases and presence of more such enzymes in extracellular milieu 
cannot be ruled out. Therefore screening other fractions might help us to solve this 
mystery. Another mycobacterial fraction where carboxylester hydrolases might get 
translocated is lipid droplets. Therefore, inspecting lipid droplets isolated from NRP 
bacilli for THL target identification is another promising goal. Moreover, very few 
lipid droplet associated α/β-hydrolases have been reported to date64. 
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6.5.2 PTM-mediated protein regulation 
 The mechanism of protein regulation during the mycobacterial NRP state is 
poorly understood. Under normal growth conditions, mycobacterial proteins are 
regulated in several ways, such as transcriptional, translational and post-translational 
modification. In this study, we studied the regulation of lipH during NRP and the most 
probable mechanism for lipH regulation could be translocation to insoluble or 
secretory fraction or protein degradation. Phosphorylation-mediated translocation of 
HSL family proteins has been reported in adipocytes and lipH, being an HSL with 7 
phosphorylation sites, might also get translocated into lipid droplets221. In addition, 
lipH has a signal sequence with a cleavage site at the N-terminal of the protein. Apart 
from lipH we have also identified several carboxylester hydrolases with such 
characteristics (Annex 1), which can be explored and studied for protein regulation 
mechanism.  
 A western blot of lipH strain cell lysate at different metabolic state towards 
antibodies raised against pupylation and phosphorylation might provide hint of lipH 
degradation and phosphorylation. 
 
6.5.3 Elucidating the substrate of lipH 
 Cannan et al. showed that lipH metabolizes synthetic short chain esters (such 
as vinyl esters and tributyrate) in in vitro enzymatic reaction171. And in chapter 5, we 
proposed that Tween 80 (ester of oleic acid) could be a lipH substrate in culture 
medium. To verify this, an in vitro biochemical reaction with lipH enzyme using 
Tween 80 can be performed and product formation can be compared with WT or 
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empty vector control. In addition, purification of lipH and crystallographic study of 
substrate property may help to identify its natural substrate. 
 
6.5.4 Validation and characterization of BCG2654c and lipM 
 Sequence and structural homology search along with computational prediction 
on certain THL targets (Annex 1, 2 and 3) have highlighted some of the genes which 
must be functionally characterized. For example, BGC2654c is a top hit identified in 
NRP and regrowth, but absent in log THL target list. This gene is a dosR regulon gene 
and is predicted to be up-regulated during hypoxic stress. BCG2654c is structurally a 
α/β-hydrolase fold protein and domain search revealed a protease domain. It is also 
considered to be a potential vaccine candidate. Another protein is a ‘Lip family’ gene, 
lipase M (lipM, BCG2299), which was traced in all metabolic stages and appears to be 
a secretory lipase with three transmembrane domains. These genes can be cloned and 
biochemically validated as approached in the current study. 
 
6.5.5 Carboxylester hydrolases in the mycobacterial starvation model 
 In lung granuloma, mycobacteria, apart from hypoxic stress also prevail under 
nutrient starvation and low pH. Previous study has demonstrated the survival of Mtb in 
nutrient depleted, oxygen-rich medium for extended periods in a non-replicating and 
drug-tolerant state104, with an in vitro nutrient starvation Mtb culture model developed 
by Loebel et al.101. Not much is known about mycobacterial survival in nutrient 
starvation NRP bacilli, but they might feed on and utilize intracellular, membrane 
lipids or even free esters in extracellular milieu as carbon source. Under such 
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circumstances, the enzymes performing lipid catabolism are poorly understood. Using 
THL as bait and performing ABPP, might help to further understand the mechanism of 
bacterial survival in initial stages of nutrient starvation.  
 
6.5.6 THL targets in human macrophages 
 Although the mechanisms for lipid accumulation during dormancy have been 
clarified, the source of such lipids is still unclear. Recent studies have shown that 
mycobacteria in lung granulomas are surrounded by foamy macrophages enriched in 
lipid droplets. The hydrolyzed products of these lipids are the probable precursors for 
mycobacteria intracellular lipids (TAGs). Catabolism of macrophage lipids and their 
transport into mycobacteria is poorly understood. A recent report on lipid catabolism 
in M. leprae-infected host cells has shown expression of HSL as a key enzyme in fatty 
acid mobilization and lipolysis, which along with mycobacterial secretory lipases 
might perform the role of lipid catabolism231. Interestingly, the sequence homology 
search revealed that the macrophage HSL is conserved in mycobacterial with lipI 
(34%) and lipH (32%) as top hits. Therefore complete understandings of the role of 
macrophage enzymes are also useful in understanding bacterial survival. 
 
6.5.7 Mechanism of THL bacteriostatic and bactericidal activity on BCG 
 Previous and current studies have shown the bacteriostatic and bactericidal 
activity of THL towards mycobacteria. But still the mechanism of THL activity on cell 
metabolism is poorly understood. Interestingly, we mapped THL targets (including 
non-carboxylester hydrolase enzymes) in mycobacterial metabolic pathways (data not 
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shown) and it revealed that THL targets central energy and lipid metabolism of 
mycobacteria. But this data requires further experimental proof such as screening of 
metabolites involved in these pathways. 
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Annex 4: Effect of THL on mycobacterial PDIM and Phenolic glycolipid (PGL). 
A. HPTLC run of mycobacterial TAG and PDIM lipids extracted from THL treated 
logarithmic phase culture. THL treatment induces accumulation of TAGs, probably 
due to inhibition on cellular TAG lipases. No significant change in PDIM lipid was 
observed. B. Two-dimensional HPTLC run of PGLs. Significant change in PGLs were 
only observed at high concentration of THL. 
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Annex 5: Ethambutol is ineffective against NRP and resuscitating cells. MIC50 of 
ethambutol (EMB), a first line anti-tuberculosis drug, did not show significant change 
in MIC50 value towards M. bovis BCG at different metabolic states. The recorded 
MIC50 values for various stages are as follows: logarithmic 3.23 µM, NRP 1.80 µM 
and regrowth 2.21 µM. 
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